Frequency and risk factors of metabolic associated fatty liver disease among medical students in Egypt Mohamed M. Elhoseeny, Fatma Rageh, Samar M. Rezk, Amira A. A. Othman Scientific Reports.2025;[Epub] CrossRef
Exploring Fibrosis Pathophysiology in Lean and Obese Metabolic-Associated Fatty Liver Disease: An In-Depth Comparison Milena Vesković, Milka Pejović, Nikola Šutulović, Dragan Hrnčić, Aleksandra Rašić-Marković, Olivera Stanojlović, Dušan Mladenović International Journal of Molecular Sciences.2024; 25(13): 7405. CrossRef
The unfolded features on the synchronized fashion of gut microbiota and Drynaria rhizome against obesity via integrated pharmacology Ki-Kwang Oh, Sang-Jun Yoon, Seol Hee Song, Jeong Ha Park, Jeong Su Kim, Min Ju Kim, Dong Joon Kim, Ki-Tae Suk Food Chemistry.2024; 460: 140616. CrossRef
Diagnosis and Management of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review Basile Njei, Prince Ameyaw, Yazan Al-Ajlouni, Lea-Pearl Njei, Sarpong Boateng Cureus.2024;[Epub] CrossRef
Non-alcoholic fatty liver disease in people with normal body weight S. V. Turkina, I. A. Tyshchenko, M. N. Titarenko Experimental and Clinical Gastroenterology.2024; (10): 36. CrossRef
Background/Aims To investigate whether non-alcoholic fatty liver disease (NAFLD) in individuals without generalized obesity is associated with visceral fat obesity (VFO), sarcopenia, and/or myosteatosis.
Methods This cross-sectional analysis included 14,400 individuals (7,470 men) who underwent abdominal computed tomography scans during routine health examinations. The total abdominal muscle area (TAMA) and skeletal muscle area (SMA) at the 3rd lumbar vertebral level were measured. The SMA was divided into the normal attenuation muscle area (NAMA) and low attenuation muscle area, and the NAMA/TAMA index was calculated. VFO was defined by visceral to subcutaneous fat ratio, sarcopenia by body mass index-adjusted SMA, and myosteatosis by the NAMA/TAMA index. NAFLD was diagnosed with ultrasonography.
Results Of the 14,400 individuals, 4,748 (33.0%) had NAFLD, and the prevalence of NAFLD among non-obese individuals was 21.4%. In regression analysis, both sarcopenia (men: odds ratio [OR] 1.41, 95% confidence interval [CI] 1.19–1.67, P<0.001; women: OR=1.59, 95% CI 1.40–1.90, P<0.001) and myosteatosis (men: OR=1.24, 95% CI 1.02–1.50, P=0,028; women: OR=1.23, 95% CI 1.04–1.46, P=0.017) were significantly associated with non-obese NAFLD after considering for VFO and other various risk factors, whereas VFO (men: OR=3.97, 95% CI 3.43–4.59 [adjusted for sarcopenia], OR 3.98, 95% CI 3.44–4.60 [adjusted for myosteatosis]; women: OR=5.42, 95% CI 4.53–6.42 [adjusted for sarcopenia], OR=5.33, 95% CI 4.51–6.31 [adjusted for myosteatosis]; all P<0.001) was strongly associated with non-obese NAFLD after adjustment with various known risk factors.
Conclusions In addition to VFO, sarcopenia and/or myosteatosis were significantly associated with non-obese NAFLD.
Citations
Citations to this article as recorded by
The Relationship Between Remnant Cholesterol and Visceral Adipose
Tissue: A National Cross-Sectional Study Zhaoxiang Wang, Shao Zhong, Menghuan Wu, Xuejing Shao, Tian Gu, Mengjiao Xu, Qichao Yang Hormone and Metabolic Research.2025; 57(01): 47. CrossRef
Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases Qi Zhong, Rui Zhou, Yi-Ning Huang, Rui-Dian Huang, Fu-Rong Li, Hao-Wen Chen, Yan-Fei Wei, Kuan Liu, Bi-Fei Cao, Kai-Yue Liao, Zheng-Yun Xu, Shi-Ao Wang, Xian-Bo Wu Journal of Hepatology.2025; 82(3): 427. CrossRef
Statin use and liver-related prognosis among patients with MASLD Byungyoon Yun, Heejoo Park, Jian Lee, Beom Kyung Kim, Jin-Ha Yoon JHEP Reports.2025; 7(4): 101313. CrossRef
AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B Hyunjae Shin, Moon Haeng Hur, Byeong Geun Song, Soo Young Park, Gi-Ae Kim, Gwanghyeon Choi, Joon Yeul Nam, Minseok Albert Kim, Youngsu Park, Yunmi Ko, Jeayeon Park, Han Ah Lee, Sung Won Chung, Na Ryung Choi, Min Kyung Park, Yun Bin Lee, Dong Hyun Sinn, Se Journal of Hepatology.2025; 82(6): 1080. CrossRef
Lymph Node Adiposity and Metabolic Dysfunction-Associated Steatotic Liver Disease Jessica M. Rubino, Natalie Yanzi Ring, Krishna Patel, Xiaoqing Xia, Todd A. MacKenzie, Roberta M. diFlorio-Alexander Biomedicines.2025; 13(1): 80. CrossRef
Is type 2 diabetes a link between lung function and metabolic dysfunction–associated steatotic liver disease? Insights from population studies and Mendelian randomization Runmin Cao, Yurun Zhang, Ling Cao, Honghe Jiang European Journal of Gastroenterology & Hepatology.2025; 37(5): 652. CrossRef
A cross-sectional study of risk factors associated with sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease Johnny Amer, Qusay Abdoh, Zaina Salous, Eithar Abu Alsoud, Sama AbuBaker, Ahmad Salhab, Manal Badrasawi Frontiers in Medicine.2025;[Epub] CrossRef
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease Mohammed Eslam, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Ian Homer Cua, Chun-Jen Liu, Tawesak Tanwandee, Rino Gani, Wai-Kay Seto, Shahinul Alam, Dan Yock Young, Saeed Hamid, Ming-Hua Zheng, Takumi Kawaguchi, Wah-Kheong Chan, Diana Payawal, Soek-S Hepatology International.2025; 19(2): 261. CrossRef
Sarcopenia and non-alcoholic fatty liver disease - complex pathogenetic relationships V. A. Akhmedov, V. S. Marinenko Experimental and Clinical Gastroenterology.2025; (9): 110. CrossRef
Effects of Pemafibrate on Serum Carnitine and Plasma Myostatin in Patients With Metabolic Dysfunction Associated Steatotic Liver Disease Ryohei Tanigawa, Atsushi Nakajima, Yuichiro Eguchi, Hirokazu Takahashi, Rohit Loomba, Hideki Suganami, Masaya Tanahashi, Hidenori Arai JCSM Communications.2025;[Epub] CrossRef
Metabolic dysfunction-associated steatotic liver disease (MASLD): Exploring systemic impacts and innovative therapies Parag Jain, Akanksha Jain, Rohitas Deshmukh, Pradeep Samal, Trilochan Satapathy, Ajazuddin Clinics and Research in Hepatology and Gastroenterology.2025; 49(6): 102584. CrossRef
Comparative Hepatic Outcomes of SGLT2i or DPP4i Compared to GLP‐1RA in CHB and T2DM Patients Byungyoon Yun, Juyeon Oh, Heejoo Park, Jian Lee, Beom Kyung Kim, Jin‐Ha Yoon Liver International.2025;[Epub] CrossRef
Skeletal muscle and MASLD: Mechanistic and clinical insights Thomas Marjot, Matthew J. Armstrong, Jonathan G. Stine Hepatology Communications.2025;[Epub] CrossRef
Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass Vasily Isakov World Journal of Gastroenterology.2025;[Epub] CrossRef
Association of lean metabolic dysfunction‐associated steatotic liver disease with carotid plaque progression in patients with type 2 diabetes mellitus Youngjoon Kim, Yongin Cho, Yong‐ho Lee, Da Hea Seo, Seong Hee Ahn, Seongbin Hong, So Hun Kim Journal of Diabetes Investigation.2025; 16(9): 1713. CrossRef
Role of estimated glucose disposal rate in predicting myosteatosis: Insights from abdominal CT analysis Myung Jin Kim, Yun Kyung Cho, Eun Hee Kim, Min Jung Lee, Woo Je Lee, Hong-Kyu Kim, Chang Hee Jung Nutrition, Metabolism and Cardiovascular Diseases.2025; : 104225. CrossRef
Thigh Muscles and Metabolic Dysfunction‐Associated Steatotic Liver Disease: Findings From the SCAPIS/IGT‐Microbiota Study Amar Osmancevic, Anders Gummesson, Matthew Allison, Joel Kullberg, Ying Li, Göran Bergström, Bledar Daka Liver International.2025;[Epub] CrossRef
Influence of Matcha and Tea Catechins on the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)—A Review of Patient Trials and Animal Studies Danuta I. Kosik-Bogacka, Katarzyna Piotrowska Nutrients.2025; 17(15): 2532. CrossRef
Associations of child-to-adult body size change with risk of hypertension and metabolic dysfunction-associated steatotic liver disease: a population-based cohort study of 226,420 individuals Fengyuan Tang, Wenqianzi Yang, Weijia Wu, Shengxuan Jin, Xuemei Zhen, Hengjin Dong BMC Public Health.2025;[Epub] CrossRef
The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with early onset type 2 diabetes with NAFLD: a cross-sectional study in China Nini Wu, Yingqun Ni, Rilong Huang, Junhua Wang, Meimei Li, Haiying Hu, Yuanyuan Zhang, Juyi Li, Jinjun Zhang Frontiers in Nutrition.2025;[Epub] CrossRef
Sarcopenia and MASLD: novel insights and the future Chang-Hai Liu, Qing-Min Zeng, Won Kim, Seung Up Kim, Zobair M. Younossi, Giovanni Targher, Christopher D. Byrne, Christos S. Mantzoros, Phunchai Charatcharoenwitthaya, Isabelle Anne Leclercq, Manuel Romero-Gómez, Hong Tang, Ming-Hua Zheng Nature Reviews Endocrinology.2025;[Epub] CrossRef
The Basics of Metabolic Dysfunction–Associated Steatotic Liver Disease for Cardiologists Muhammad Shahzeb Khan, Syed Sarmad Javaid, Amreen Dinani, Kara Wegermann, Ambarish Pandey, Ankeet S. Bhatt, Mark Muthiah, Harriette G.C. Van Spall, Faiez Zannad, Javed Butler, Michael L. Volk, Marat Fudim JACC.2025; 86(20): 1861. CrossRef
Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis Aikaterini Kamiliou, Vasileios Lekakis, Lampros Chrysavgis, Evangelos Cholongitas Hepatology International.2024; 18(2): 688. CrossRef
Prevalence of and Impact on the Outcome of Myosteatosis in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis Aikaterini Kamiliou, Vasileios Lekakis, George Xynos, Evangelos Cholongitas Cancers.2024; 16(5): 952. CrossRef
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting Alina M. Allen, Michael Charlton, Kenneth Cusi, Stephen A. Harrison, Kris V. Kowdley, Mazen Noureddin, Jay H. Shubrook Postgraduate Medicine.2024; 136(3): 229. CrossRef
Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options Piero Portincasa, Mohamad Khalil, Laura Mahdi, Valeria Perniola, Valeria Idone, Annarita Graziani, Gyorgy Baffy, Agostino Di Ciaula International Journal of Molecular Sciences.2024; 25(11): 5640. CrossRef
Association between metabolic dysfunction‐associated steatotic liver disease and myosteatosis measured by computed tomography Myung Jin Kim, Yun Kyung Cho, Eun Hee Kim, Min Jung Lee, Woo Je Lee, Hong‐Kyu Kim, Chang Hee Jung Journal of Cachexia, Sarcopenia and Muscle.2024; 15(5): 1942. CrossRef
The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis Xiaoyan Li, Jie He, Qiuhua Sun Clinical Nutrition.2024; 43(9): 2005. CrossRef
Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular c Toru Nakamura, Masahito Nakano, Tsubasa Tsutsumi, Keisuke Amano, Takumi Kawaguchi Clinical and Molecular Hepatology.2024; 30(4): 705. CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated with Increased Risk of Kidney Cancer: A Nationwide Study Juyeon Oh, Beom Kyung Kim, Jin-Ha Yoon, Hyung Ho Lee, Heejoo Park, Jian Lee, Youngsun Park, Byungyoon Yun, Jinsoo Chung Cancers.2024; 16(18): 3161. CrossRef
Diagnosis and management of metabolic dysfunction- associated steatotic liver disease in South Asians- A clinical review Prajith Raj Ramesh, Priya Krishnan, Samyuktha Prabu, Varshini Srinivasan, Varalakshmi Niranjan Obesity Pillars.2024; 12: 100142. CrossRef
Diagnosis and Management of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review Basile Njei, Prince Ameyaw, Yazan Al-Ajlouni, Lea-Pearl Njei, Sarpong Boateng Cureus.2024;[Epub] CrossRef
Reply to correspondence on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis” Tian-Yi Ren, Mohammed Eslam, Jian-Gao Fan Clinical and Molecular Hepatology.2024; 30(4): 1039. CrossRef
Correspondence to editorial on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis” Hayeon Kim, Min Jeong Park, Myeong Gyu Kim, Kyungim Kim Clinical and Molecular Hepatology.2024; 30(4): 989. CrossRef
Correlation and predictive value of novel anthropometric indicators with adult sarcopenia and sarcopenia obesity Xue Wu, Ziang Chen, Yuanhui Zhao, Hong Ren Scientific Reports.2024;[Epub] CrossRef
Sarcopenia as a Risk Factor for Mortality in NAFLD: How Should We Diagnose It? Catherine Stankevicius, Rachel H. Davis, Dep Huynh, Martine Hatzi, Stephanie Morgillo, Alice S. Day Journal of Digestive Diseases.2024; 25(11-12): 645. CrossRef
Non-alcoholic fatty liver disease in people with normal body weight S. V. Turkina, I. A. Tyshchenko, M. N. Titarenko Experimental and Clinical Gastroenterology.2024; (10): 36. CrossRef
Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean? Eugene Han, Yong-ho Lee Clinical and Molecular Hepatology.2023; 29(4): 980. CrossRef
Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved Baris Afsar, Rengin Elsurer Afsar Clinical Nutrition.2023; 42(12): 2338. CrossRef
The newly proposed Metabolic Score for Visceral Fat is a reliable tool for identifying non-alcoholic fatty liver disease, requiring attention to age-specific effects in both sexes Maobin Kuang, Jiajun Qiu, Dongdong Li, Chong Hu, Shuhua Zhang, Guotai Sheng, Yang Zou Frontiers in Endocrinology.2023;[Epub] CrossRef
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, with a global prevalence estimated at approximately 25%. NAFLD is also the leading cause of liver cirrhosis, hepatocellular carcinoma, and death. Additionally, the risk of cardiovascular disease increases with greater NAFLD severity. The liver- and cardiovascular disease-related mortality incident rate ratios among the NAFLD population were 0.77 and 4.79 per 1,000 person-years, respectively. We intend to discuss the risk factors associated with NAFLD in terms of development and progression. Obesity or higher body mass index is closely associated with NAFLD in a dose-dependent manner, but growing evidence suggests that central obesity plays a more important role in the development of NAFLD. Saturated fat and fructose have been reported to be closely related to NAFLD. Fructose intake promotes lipogenesis and impairs mitochondria fat oxidation. The presence of type 2 diabetes is the most powerful predictive risk factor for hepatic fibrosis in patients with NAFLD. Single nucleotide polymorphism is not only associated with the prevalence of NAFLD but also associated with increased liver disease mortality. Obstructive sleep apnea, intestinal dysbiosis, and sarcopenia are associated with the development of NAFLD
Citations
Citations to this article as recorded by
Quantitative Liver Fat Assessment by Handheld Point-of-Care Ultrasound: A Technical Implementation and Pilot Study in Adults Dorathy Tamayo-Murillo, Jake T. Weeks, Cody A. Keller, Michael Andre, Celene Gonzalez, Andrew Li, Eduardo Grunvald, Joy Liau, Sedighe Hosseini Shabanan, Tanya Wolfson, Jingyi Zuo, Adam Robinson, Carolina Amador Carrascal, Nevada Sanchez, Scott B. Reeder, Ultrasound in Medicine & Biology.2025; 51(3): 475. CrossRef
Decompensated Cirrhosis with Hepatopulmonary Syndrome in a Patient with Interrupted Treatment for Hypopituitarism Tomoko Tadokoro, Joji Tani, Yudai Sato, Rie Yano, Kei Takuma, Mai Nakahara, Kyoko Oura, Koji Fujita, Masafumi Ono, Atsushi Tobiume, Seisuke Sato, Takuya Inoue, Asahiro Morishita, Hideki Kobara Internal Medicine.2025; 64(15): 2307. CrossRef
Smoking and Risk of Fatty Liver Disease: A Meta-Analysis of Cohort Studies Moonhyung Lee, Seung-Kwon Myung, Sang Hee Lee, Yoosoo Chang Gastroenterology Insights.2025; 16(1): 1. CrossRef
Is type 2 diabetes a link between lung function and metabolic dysfunction–associated steatotic liver disease? Insights from population studies and Mendelian randomization Runmin Cao, Yurun Zhang, Ling Cao, Honghe Jiang European Journal of Gastroenterology & Hepatology.2025; 37(5): 652. CrossRef
Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome Analysis Gina Ryu, Eileen Laurel Yoon, Wankyu Kim, Dae Won Jun Diagnostics.2025; 15(3): 342. CrossRef
A novel 11β-HSD1 inhibitor ameliorates liver fibrosis by inhibiting the notch signaling pathway and increasing NK cell population Ji Eun Kim, Yun Kim, Jiwon Bae, Eileen Laurel Yoon, Hyun Sung Kim, Sung Ryol Lee, Tae Hyun Yoon, Dae Won Jun Archives of Pharmacal Research.2025; 48(2): 166. CrossRef
Transcriptomic analysis reveals the mechanisms underlying the differential effects of caffeine, theophylline, and theobromine in regulating hepatic fat accumulation Jinya Dong, Xiaocui Du, Ruijuan Yang, Linxian Shan, Xiuli Lu, Yan Shen, Yanmei Li, Shengjie Duan, Zezhu Du, Jianyang Fu, Jun Sheng, Chongye Fang Food & Function.2025; 16(6): 2503. CrossRef
Epidemiological Dynamics of Burden and Health Inequalities in Metabolic Dysfunction-associated Steatotic Liver Disease in Adolescents at Global, Regional, and National Levels, 1990–2021 Xiaohui Sui, Junde Zhao, Yuxin Yang, Yikun Yang, Kaifeng Li, Zuocheng Wang, Ziqi Liu, Ruining Lu, Guiju Zhang Journal of Clinical and Experimental Hepatology.2025; 15(4): 102537. CrossRef
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease Mohammed Eslam, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Ian Homer Cua, Chun-Jen Liu, Tawesak Tanwandee, Rino Gani, Wai-Kay Seto, Shahinul Alam, Dan Yock Young, Saeed Hamid, Ming-Hua Zheng, Takumi Kawaguchi, Wah-Kheong Chan, Diana Payawal, Soek-S Hepatology International.2025; 19(2): 261. CrossRef
Editorial: Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Hyo Young Lee, Dae Won Jun Alimentary Pharmacology & Therapeutics.2025; 61(9): 1545. CrossRef
Non-alcoholic fatty liver disease: diet therapy and pharmacotherapy M. L. Maksimov, V. A. Dudareva, V. O. Vovk, V. I. Sklyarova, S. O. Ivashchenko, A. A. Shikaleva Terapevt (General Physician).2025; (3): 37. CrossRef
Serum uric acid may be a mediator of risk factors in metabolic dysfunction associated steatotic liver disease Xueying Wang, Song Leng Scandinavian Journal of Gastroenterology.2025; 60(6): 581. CrossRef
Gut microbiota-derived metabolite phenylacetylglutamine in cardiovascular and metabolic diseases Wan Chen, Mei-Ling Li, Guang Zeng, Xiang-Yu Xu, Shan-Hui Yin, Can Xu, Linlin Li, Kaikai Wen, Xiao-Hua Yu, Gang Wang Pharmacological Research.2025; 217: 107794. CrossRef
Cost-effectiveness analysis of MASLD screening using FIB-4 based two-step algorithm in the medical check-up Mimi Kim, Huiyul Park, Eileen L. Yoon, Ramsey Cheung, Donghee Kim, Hye-Lin Kim, Dae Won Jun Scientific Reports.2025;[Epub] CrossRef
Efficacy and safety of time-restricted eating in metabolic dysfunction-associated steatotic liver disease Joo Hyun Oh, Eileen L. Yoon, Huiyul Park, Seungmin Lee, Ae Jeong Jo, Seon Cho, Eunjoo Kwon, Eun-Hee Nah, Jun-Hyuk Lee, Jung Hwan Park, Sang Bong Ahn, Dae Won Jun Journal of Hepatology.2025; 83(6): 1256. CrossRef
Pathogenic effects of telomerase reverse transcriptase (TERT) promoter mutations in nonalcoholic steatohepatitis (NASH) related hepatocellular carcinoma (HCC) and its potentials as a diagnostic biomarker Usman Umar Liman, Asanka Sudeshini Hawage, Sumadee De Silva, Saumya Madushani Samarasinghe, Kamani Hemamala Tennekoon, Rohan Chaminda Siriwardana, Madunil Anuk Niriella Egyptian Journal of Medical Human Genetics.2025;[Epub] CrossRef
Cadmium exposure and weight-adjusted waist index: Interactions with selenium in modulating hepatic fibrosis Chenggang Yang, Mengru Hao, Junying Zhu, Yutian Luo, Alexey A. Tinkov, Olga S. Ignatovets, Shimiao Dai, Zhan Shi, Yuqing Chen, Ji-Chang Zhou Food and Chemical Toxicology.2025; 204: 115613. CrossRef
High sensitivity C-reactive protein may be a significant predictor of non-alcoholic fatty liver disease in non-obese adults: A four-year retrospective study Changxi Chen, Jiande Gong, Mengting Li, Shiyu Pan, Guitao Xia, Yuemei Xu, Hongliang Li, Qi Lin Nutrition, Metabolism and Cardiovascular Diseases.2025; 35(12): 104224. CrossRef
Association between waist circumference and fatty liver disease in older adult population: a cross-sectional study in Urumqi Mingdong Zhang, E. Zhao, Gaofeng Sun Frontiers in Public Health.2025;[Epub] CrossRef
Obstructive sleep apnea and metabolic-associated fatty liver disease risk: Insights from National Health and Nutrition Examination Survey and Mendelian randomization analysis Cao Beibei, Zhen Junhai, Tan Zongbiao, Peng Fang Nutrition, Metabolism and Cardiovascular Diseases.2025; : 104265. CrossRef
Tracking Mutual Interactions of Mitochondria/Lysosomes/Lipid Droplets in DILI and NAFLD with a Viscosity and Peroxynitrite-Sensitive Single Fluorescent Probe Chunhua Fan, Xionghao Xu, Bo Zhao, Tao Jiang, Tianxin Liu, Chaewoon Cho, Juyoung Yoon, Zhengliang Lu Analytical Chemistry.2025; 97(40): 21935. CrossRef
From steatosis to cirrhosis: the role of obesity in the progression of liver disease Klaudia Nowak, Maria Paluch, Maja Cudzik, Klaudia Syska, Wiktoria Gawlikowska, Jakub Janczura Journal of Diabetes & Metabolic Disorders.2025;[Epub] CrossRef
Allyl nonanoate as a novel bile-derived biomarker in metabolic dysfunction-associated steatotic liver disease Soo Hyeon Lee, Jonghwan Kim, Sung Ryol Lee, Bum Soo Lee, Ki Hyun Kim, Dae Won Jun, Chung Sub Kim, Kyung A Kang Frontiers in Endocrinology.2025;[Epub] CrossRef
Associations between metabolic score for visceral fat and nonalcoholic fatty liver disease (NAFLD) in US adults: A cross-sectional study based on NHANES 2017–2020 Juan Li, Shenglan Dai Medicine.2025; 104(46): e45082. CrossRef
Cardiac remodelling in novel cluster-based metabolic (dysfunction)-associated fatty liver disease: a cross-sectional study in China Yina Wang, Xiaolan Ouyang, Na Ye, Weilan Huang, Ying Zhou, Shangyan Liang, Sijing Luo, Xiumei Tang, Boxiong Jiang, Xixiang Tang BMJ Open.2025; 15(11): e102845. CrossRef
Association between serum trace element, mineral, and amino acid levels with non-alcoholic fatty liver disease (NAFLD) in adult women Alexey A. Tinkov, Tatiana V. Korobeinikova, Galina D. Morozova, Michael Aschner, Daria V. Mak, Abel Santamaria, Joao B.T. Rocha, Tatiana I. Sotnikova, Serafima Ia. Tazina, Anatoly V. Skalny Journal of Trace Elements in Medicine and Biology.2024; 83: 127397. CrossRef
Adverse pregnancy outcomes as a risk factor for new-onset metabolic dysfunction-associated steatotic liver disease in postpartum women: A nationwide study Young Mi Jung, Seung Mi Lee, Wonyoung Wi, Min-Jeong Oh, Joong Shin Park, Geum Joon Cho, Won Kim JHEP Reports.2024; 6(4): 101033. CrossRef
Hybrid Quantum Image Classification and Federated Learning for Hepatic Steatosis Diagnosis Luca Lusnig, Asel Sagingalieva, Mikhail Surmach, Tatjana Protasevich, Ovidiu Michiu, Joseph McLoughlin, Christopher Mansell, Graziano de’ Petris, Deborah Bonazza, Fabrizio Zanconati, Alexey Melnikov, Fabio Cavalli Diagnostics.2024; 14(5): 558. CrossRef
Characterisation and beneficial effects of a Lupinus angustifolius protein hydrolysate obtained by immobilisation of the enzyme alcalase® Guillermo Santos-Sánchez, Ivan Cruz-Chamorro, José Carlos Márquez-López, Justo Pedroche, Ana Isabel Álvarez-López, María del Carmen Millán-Linares, Patricia Judith Lardone, Antonio Carrillo-Vico Food & Function.2024; 15(7): 3722. CrossRef
Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences Joo Hyun Oh, Dae Won Jun Clinical and Molecular Hepatology.2024; 30(2): 168. CrossRef
Gestational supplementation of Bifidobacterium, Lactobacillus, and Streptococcus thermophilus attenuates hepatic steatosis in offspring mice through promoting fatty acid β‐oxidation Hangjun Chen, Qiongmei Wu, Xingyi Chen, Xinxue Yu, Hanqing Zhao, Qiaoli Huang, Yurong Huang, Jinting Wang, Xueyi Huang, Jun Wei, Feng Wu, Xiaomin Xiao, Lijun Wang Journal of Food Science.2024; 89(5): 3064. CrossRef
Polyethersulfone Polymer for Biomedical Applications and Biotechnology Monika Wasyłeczko, Cezary Wojciechowski, Andrzej Chwojnowski International Journal of Molecular Sciences.2024; 25(8): 4233. CrossRef
The gut-liver axis in fatty liver disease: role played by natural products Zhu Ming, Xie Ruishi, Xu Linyi, Yang Yonggang, Luo Haoming, Lan Xintian Frontiers in Pharmacology.2024;[Epub] CrossRef
Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction‐associated fatty liver disease: A cross‐sectional study of NHANES 2017–2018 Zhiliang Mai, Yinfei Chen, Hua Mao, Lisheng Wang Journal of Diabetes.2024;[Epub] CrossRef
Association between hemoglobin and non-alcoholic fatty liver disease (NAFLD) in United States adults: Results from NHANES 2017–2020 Kang Yao, Zheng Chen, Wei Zhou, Zhihua Liu, Wei Cui Preventive Medicine Reports.2024; 44: 102798. CrossRef
Metabolic dysfunction–associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity Jie Tao, Hong Li, Honggang Wang, Juan Tan, Xiaozhong Yang Osteoporosis International.2024; 35(12): 2087. CrossRef
Knowledge, Attitudes, and Determinants of Nonalcoholic Fatty Liver Disease Among Adults in Jazan Province: A Cross-Sectional Study Ali M Someili, Mostafa Mohrag, Bandar S Rajab, Abdulrahman A Daghreeri, Fawaz M Hakami, Riyadh A Jahlan, Abdulrahman A Otaif, Abdulelah A Otaif, Hussam T Hakami, Bandar F Daghriri, Ameer M Mobarki, Rakan B Almjlad, Mousa Mobarki Cureus.2024;[Epub] CrossRef
Reply to correspondence on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study” Eileen Laurel Yoon, Dae Won Jun Clinical and Molecular Hepatology.2024; 30(4): 1033. CrossRef
Silybin: A Review of Its Targeted and Novel Agents for Treating Liver Diseases Based on Pathogenesis Jijiao Wu, Lin Wen, Xiaolian Liu, Qiuxia Li, Zihao Sun, Chuipeng Liang, Fan Xie, Xiaofang Li Phytotherapy Research.2024; 38(12): 5713. CrossRef
Acute Toxicity and Hepatoprotective Influence of Hypericum perforatum Against Thioactamid-Induced Liver Fibrosis in Rats Ahmed A.J. Jabbar, Zaenah Zuhair Alamri Natural Product Communications.2024;[Epub] CrossRef
The Role of Dietary Ingredients and Herbs in the Prevention of Non-Communicable Chronic Liver Disease Monika Maćków, Tomasz Dziubyna, Tatiana Jamer, Dmytro Slivinskyi, Tomasz Pytrus, Katarzyna Neubauer, Małgorzata Zwolińska-Wcisło, Andrzej Stawarski, Ewa Piotrowska, Dorian Nowacki Nutrients.2024; 16(20): 3505. CrossRef
Phytochemical Profiling, Acute Toxicity, and Hepatoprotective Effects of Anchusa Limbata in Thioacetamide‐Induced Liver Cirrhosis in Rats Khaled Abdul‐Aziz Ahmed, Ahmed A. J. Jabbar, Mohammed M. Hussein M. Raouf, Ayman M. Al‐Qaaneh, Rawaz Rizgar Hassan, Musher Ismael Salih, Ramzi A. Mothana, Gadah Abdulaziz Al‐Hamoud, Mahmood Ameen Abdulla, Sidgi Hasson, Parween Abdul‐samad Ismail Food Science & Nutrition.2024; 12(12): 10628. CrossRef
Quantificação da gordura hepática: avaliação de diferentes estratégias de medidas pela ressonância magnética nos casos de distribuição homogênea e heterogênea Eloa de Castro Noguerol, Luis Ronan Marquez Ferreira de Souza, Valdair Francisco Muglia, Jorge Elias Jr. Radiologia Brasileira.2024;[Epub] CrossRef
Quantification of hepatic fat: evaluation of different magnetic resonance imaging measurement strategies in cases of homogeneous and heterogeneous distribution Eloa de Castro Noguerol, Luis Ronan Marquez Ferreira de Souza, Valdair Francisco Muglia, Jorge Elias Jr. Radiologia Brasileira.2024;[Epub] CrossRef
LDHA- Mediated Histone Lactylation Promotes the Nonalcoholic Fatty Liver Disease Progression Through Targeting The METTL3/ YTHDF1/SCD1 m6A Axis J Meng, C Yan, J Liu Physiological Research.2024; : 985. CrossRef
Optimal choice of diet and food for NAFLD G. V. Shavkuta, L. B. Lazebnik Experimental and Clinical Gastroenterology.2024; (10): 98. CrossRef
Efficacy of probiotics on nonalcoholic fatty liver disease: A meta-analysis Xiangyu Zhou, Jincheng Wang, Sufang Zhou, Jiajia Liao, Zuoyu Ye, Leiming Mao Medicine.2023; 102(4): e32734. CrossRef
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology Eileen Laurel Yoon, Dae Won Jun Clinical and Molecular Hepatology.2023; 29(2): 371. CrossRef
The growing burden of non-alcoholic fatty liver disease on mortality Ju-Yeon Cho, Won Sohn Clinical and Molecular Hepatology.2023; 29(2): 374. CrossRef
Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors? Heejoon Jang, Won Kim Clinical and Molecular Hepatology.2023; 29(2): 381. CrossRef
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study Eugene Han, Ho Soo Chun, Yong‐ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Sang Hoon Ahn, Seung Up Kim Journal of Gastroenterology and Hepatology.2023; 38(9): 1598. CrossRef
Moderate- and High-Intensity Endurance Training Alleviate Diabetes-Induced Cardiac Dysfunction in Rats Sarah D’Haese, Maxim Verboven, Lize Evens, Dorien Deluyker, Ivo Lambrichts, BO Eijnde, Dominique Hansen, Virginie Bito Nutrients.2023; 15(18): 3950. CrossRef
Waiting for the changes after the adoption of steatotic liver disease Eileen L. Yoon, Dae Won Jun Clinical and Molecular Hepatology.2023; 29(4): 844. CrossRef
Letter regarding “Risk factors in nonalcoholic fatty liver disease” Abhijit Pratap, Umesh More, Pradnya Phalak, Anita Deshmukh Clinical and Molecular Hepatology.2023; 29(4): 1046. CrossRef
Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity Hong-Kyu Kim, Sung-Jin Bae, Min Jung Lee, Eun Hee Kim, Hana Park, Hwi Seung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee, Jaewon Choe Clinical and Molecular Hepatology.2023; 29(4): 987. CrossRef
Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease” Eileen L. Yoon, Dae Won Jun Clinical and Molecular Hepatology.2023; 29(4): 1050. CrossRef
Association of fat-to-muscle ratio with non-alcoholic fatty liver disease: a single-centre retrospective study Fengqin Yan, Guqiao Nie, Nianli Zhou, Meng Zhang, Wen Peng BMJ Open.2023; 13(10): e072489. CrossRef
International diet quality index and revised diet quality index relationship with non-alcoholic fatty liver disease: a case-control study Narjes Najibi, Mitra Kazemi Jahromi, Farshad Teymoori, Hossein Farhadnejad, Ammar Salehi-Sahlabadi, Parvin Mirmiran BMC Gastroenterology.2023;[Epub] CrossRef
Sarcopenia and nonalcoholic fatty liver disease (NAFLD) are common health problems related to aging. Despite the differences in their diagnostic methods, several cross-sectional and longitudinal studies have revealed the close link between sarcopenia and NAFLD. Sarcopenia and NAFLD are linked by several shared pathogenetic mechanisms, including insulin resistance, hormonal imbalance, systemic inflammation, myostatin and adiponectin dysregulation, nutritional deficiencies, and physical inactivity, thus implicating a bidirectional relationship between sarcopenia and NAFLD. However, there is not sufficient data to support a direct causal relationship between sarcopenia and NAFLD. Moreover, it is currently difficult to conclude whether sarcopenia is a risk factor for nonalcoholic steatohepatitis (NASH) or is a consequence of NASH. Therefore, this review intends to touch on the shared common mechanisms and the bidirectional relationship between sarcopenia and NAFLD.
Citations
Citations to this article as recorded by
Development and external validation of a machine-learning based model to predict pre-sarcopenia in MASLD population: Results from NHANES 2017–2018 Siwei Yang, Jianan Yu, Qiyang Chen, Xuedong Sun, Yuefeng Hu, Tianhao Su, Jian Li, Long Jin Annals of Hepatology.2025; 30(2): 101585. CrossRef
Appendicular skeletal muscle mass is associated with metabolic dysfunction-associated steatotic liver disease severity in young men: a cross-sectional and longitudinal study Jaejun Lee, Jinson So, Chang In Han, Hyun Yang, Pil Soo Sung, Si Hyun Bae, Do Seon Song Hepatology International.2025; 19(1): 181. CrossRef
New nomenclature and subclassification of steatotic liver disease and loss of skeletal muscle mass: A longitudinal cohort study Aryoung Kim, Danbee Kang, Sung Chul Choi, Dong Hyun Sinn, Geum‐Youn Gwak Hepatology Research.2025; 55(3): 373. CrossRef
Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States Fan Zhang, Longgen Liu, Wenjian Li Nutrition Journal.2025;[Epub] CrossRef
Additive impact of metabolic syndrome and sarcopenia on all-cause and cause-specific mortality: an analysis of NHANES Meng Zhang, Qing-Yue Zeng, Linli Zhuang Frontiers in Endocrinology.2025;[Epub] CrossRef
Sarcopenia and metabolic dysfunction-associated steatotic liver disease: The role of exercise-related biomarkers Marwan S Al-Nimer World Journal of Hepatology.2025;[Epub] CrossRef
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease Mohammed Eslam, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Ian Homer Cua, Chun-Jen Liu, Tawesak Tanwandee, Rino Gani, Wai-Kay Seto, Shahinul Alam, Dan Yock Young, Saeed Hamid, Ming-Hua Zheng, Takumi Kawaguchi, Wah-Kheong Chan, Diana Payawal, Soek-S Hepatology International.2025; 19(2): 261. CrossRef
Is type 2 diabetes a link between lung function and metabolic dysfunction–associated steatotic liver disease? Insights from population studies and Mendelian randomization Runmin Cao, Yurun Zhang, Ling Cao, Honghe Jiang European Journal of Gastroenterology & Hepatology.2025; 37(5): 652. CrossRef
Sarcopenia and non-alcoholic fatty liver disease - complex pathogenetic relationships V. A. Akhmedov, V. S. Marinenko Experimental and Clinical Gastroenterology.2025; (9): 110. CrossRef
Association between sarcopenia and the prevalence of gallstone in US adults: a cross-sectional analysis of NHANES Bo Wang, Qianxi Huang, Yongqiang Xiong, Na Huang, Jun Li, Shu Zhang BMC Gastroenterology.2025;[Epub] CrossRef
Associations of Serum Vitamin D with Sarcopenia in Patients with Chronic Liver Disease: A Population‐Based Cross‐Sectional Study Xinxing Tantai, Zhang Wen, Shuyue Tuo, Qiuju Ran, Chan Li, Yong Li, Jia Yuan, Jinhai Wang, Lu Li, Shejiao Dai Calcified Tissue International.2025;[Epub] CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease, Recent Revision of Terminology and Its Implications Hyo Young Lee, Eileen L. Yoon The Korean Journal of Gastroenterology.2025; 85(2): 126. CrossRef
Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia Marina Ribas Losasso, Maria Luiza Cesto Parussolo, Antony Oliveira Silva, Rosa Direito, Karina Quesada, Claudia Rucco Penteado Detregiachi, Marcelo Dib Bechara, Nahum Méndez-Sánchez, Ludovico Abenavoli, Adriano Cressoni Araújo, Ricardo de Alvares Goulart, International Journal of Molecular Sciences.2025; 26(10): 4673. CrossRef
Mechanomedicine for Addressing Skeletal Muscle Insulin Resistance Lu Wang, Le Chang, Yufei Ma, Yuanbo Jia, Bin Gao, Wei Cui, Feng Xu Endocrine Reviews.2025; 46(5): 652. CrossRef
Features of Management of Patients with NAFLD and Sarcopenia M. E. Statsenko, R. G. Myazin, M. N. Ustinova, A. V. Tumarenko The Russian Archives of Internal Medicine.2025; 15(3): 178. CrossRef
L-Ornithine salts as somatotropic axis modulators for the correction of sarcopenia in chronic liver disease V. A. Prikhodko, S. V. Okovityi Meditsinskiy sovet = Medical Council.2025; (8): 80. CrossRef
Relationship between metabolic dysfunction-associated steatotic liver disease and sarcopenia: A systematic review and meta-analyses Ninglin Xia, Jiwei Wang, Qian Lu, Xue Fan, Zhenzhou Jiang, Qinwei Yu Clinical Nutrition ESPEN.2025; 68: 679. CrossRef
Comparison of sarcopenia screening indices using serum creatinine and cystatin C in metabolic dysfunction-associated steatotic liver disease Inyoung Hwang, Shi-Ra Lee, Yun Kim, Sang Won Lee Frontiers in Medicine.2025;[Epub] CrossRef
Multimodal data-driven prognostic model for predicting long-term outcomes in older adult patients with sarcopenia: a retrospective cohort study Mengdie Liu, Wen Guo, Jin Peng, Jinhui Wu Frontiers in Public Health.2025;[Epub] CrossRef
Metabolic and immune links between sarcopenia and liver disease Stanislav Nikolaevich Kotlyarov World Journal of Hepatology.2025;[Epub] CrossRef
The Relationship Between FIB-4 Score and Dynapenia in Older Adults Guner Kilic, Ali Karatas, Mehmet Cindoruk, Tarkan Karakan, Derya Kirman, Beril Demir, Suleyman Emre Kocyigit Diagnostics.2025; 15(18): 2323. CrossRef
Effects and Mechanisms of Long-Term Lycium barbarum Water Consumption on Skeletal Muscle Function in Aged Mice Yundi Tang, Qingwei Zheng, Jinyi Wang, Mingcong Fan, Haifeng Qian, Li Wang, Yan Li Foods.2025; 14(17): 3049. CrossRef
The relationship between MAFLD and CVD in a health check-up Chinese population: a prospective cohort study Yao Dou, Jiawei Cui, Qi Gu, Xiwei Yuan, Mengmeng Hou, Wenjing Ni, Chen Dong, Chudi Chang, Jinhua Shao, Qiuling Wang, Jie Li, Liang Qiao, Yuemin Nan Therapeutic Advances in Chronic Disease.2025;[Epub] CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease and Sarcopenia: Influence of Habitual Food Naiade S. Almeida, Raquel Rocha, Carla Daltro, Helma P. Cotrim Diagnostics.2025; 15(21): 2711. CrossRef
Oral–Sarcopenia nexus in health disparities: chewing and blood mediated pathways in a Chinese aging cohort Yong Xiang, Guosong Wang, Yiting Cheng, Yuhan Zhang, Jialiang Zhao, Birong Dong, He Cai, Li Cheng, Tao Hu BMC Oral Health.2025;[Epub] CrossRef
Body Composition in Chronic Liver Disease Hiroki Nishikawa, Soo Ki Kim, Akira Asai International Journal of Molecular Sciences.2024; 25(2): 964. CrossRef
Metabolic-associated fatty liver disease and sarcopenia: A double whammy Aditya Viswanath, Sherouk Fouda, Cornelius James Fernandez, Joseph M Pappachan World Journal of Hepatology.2024; 16(2): 152. CrossRef
The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations Ziyan Feng, Fanrong Zhao, Ziyao Wang, Xinyi Tang, Yan Xie, Li Qiu BMC Gastroenterology.2024;[Epub] CrossRef
Systemic immune-inflammation index and all-cause and cause-specific mortality in sarcopenia: a study from National Health and Nutrition Examination Survey 1999-2018 Qing-Yue Zeng, Yu Qin, Yi Shi, Xing-Yu Mu, Shi-Jun Huang, Yu-Hao Yang, Si-Min Liu, Zhen-Mei An, Shuang-Qing Li Frontiers in Immunology.2024;[Epub] CrossRef
Quick and easy assessment of sarcopenia in cirrhosis: Can ultrasound be the solution? Francesca Campani, Tancredi Vincenzo Li Cavoli, Umberto Arena, Fabio Marra, Erica Nicola Lynch, Claudia Campani World Journal of Gastroenterology.2024; 30(17): 2287. CrossRef
Machine Learning Reveals Serum Glycopatterns as Potential Biomarkers for the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) Xiaocheng Li, Yaqing Xiao, Xinhuan Chen, Yayun Zhu, Haoqi Du, Jian Shu, Hanjie Yu, Xiameng Ren, Fan Zhang, Jing Dang, Chen Zhang, Shi Su, Zheng Li Journal of Proteome Research.2024; 23(6): 2253. CrossRef
Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both Rochelle Wong, Li-Yun Yuan World Journal of Hepatology.2024; 16(6): 871. CrossRef
Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B Hyunjae Shin, Gyung Sun Lim, Jae Woong Yoon, Yunmi Ko, Youngsu Park, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Yuri Cho, Yun Bin Lee, Eun Ju Cho, Bo Hyun Kim, Jeong‐Hoon Lee, Su Jong Yu, Jung‐Hwan Yoon, Yoon Jun Kim Journal of Medical Virology.2024;[Epub] CrossRef
Sarcopenia-related traits and 10 digestive system disorders: insight from genetic correlation and Mendelian randomization Tao Yang, Zheng Liu, Mingzhu Xiu, Xiaoman Qing, Sha Liu, Wanmeng Xiao, Muhan Lü Frontiers in Public Health.2024;[Epub] CrossRef
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases Reddemma Sandireddy, Suganya Sakthivel, Priyanka Gupta, Jatin Behari, Madhulika Tripathi, Brijesh Kumar Singh Frontiers in Cell and Developmental Biology.2024;[Epub] CrossRef
The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis Xiaoyan Li, Jie He, Qiuhua Sun Clinical Nutrition.2024; 43(9): 2005. CrossRef
Bibliometric and visualized analysis of the correlation between sarcopenia and chronic liver diseases from 2000 to 2023 Jiaming Lan, Haozhuo Guo, Jingyu Zou, Jian Xue, Hongbo Ni, Liuchun Wang, Tianhang Ren, Sijie Chai, Haoyang Jiang, Chan Gou, Fan Wang, Shuai Wang, Xiaohe Xu, Yue Wang, Meng Niu Portal Hypertension & Cirrhosis.2024; 3(3): 139. CrossRef
Sarcopenia: A review Chieh Chen, Da-Ming Liao Tungs' Medical Journal.2024; 18(Suppl 1): S23. CrossRef
The ZJU index is associated with the risk of sarcopenia in American adults aged 20–59: a cross-sectional study Jia-qi Hao, Shu-yue Hu, Zi-xuan Zhuang, Jia-wan Zhang, Meng-rui Xiong, Rui Wang, Wen Zhuang, Mo-jin Wang Lipids in Health and Disease.2024;[Epub] CrossRef
Sarcopenia as a Risk Factor for Mortality in NAFLD: How Should We Diagnose It? Catherine Stankevicius, Rachel H. Davis, Dep Huynh, Martine Hatzi, Stephanie Morgillo, Alice S. Day Journal of Digestive Diseases.2024; 25(11-12): 645. CrossRef
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives Riccardo Nevola, Raffaella Epifani, Simona Imbriani, Giovanni Tortorella, Concetta Aprea, Raffaele Galiero, Luca Rinaldi, Raffaele Marfella, Ferdinando Carlo Sasso International Journal of Molecular Sciences.2023; 24(2): 1703. CrossRef
Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease Goh Eun Chung, Sohee Oh, Dong-Won Ahn, Su Hwan Kim, Yong Jin Jung, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, Ji Bong Jeong Scientific Reports.2023;[Epub] CrossRef
Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease Ik Hyun Jo, Do Seon Song, U Im Chang, Jin Mo Yang Scientific Reports.2023;[Epub] CrossRef
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology Eileen Laurel Yoon, Dae Won Jun Clinical and Molecular Hepatology.2023; 29(2): 371. CrossRef
Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different? Ho Soo Chun, Minjong Lee Clinical and Molecular Hepatology.2023; 29(2): 377. CrossRef
Sarkopenie bei chronischen Lebererkrankungen Monika Rau Die Innere Medizin.2023; 64(6): 525. CrossRef
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study Eugene Han, Ho Soo Chun, Yong‐ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Sang Hoon Ahn, Seung Up Kim Journal of Gastroenterology and Hepatology.2023; 38(9): 1598. CrossRef
Lean nonalcoholic fatty liver disease and sarcopenia Milian Chen, Ying Cao, Guang Ji, Li Zhang Frontiers in Endocrinology.2023;[Epub] CrossRef
Aerobic and Resistance Exercise: Synergistic Influence for Nonalcoholic Fatty Liver Disease Ho Soo Chun Gut and Liver.2023; 17(4): 485. CrossRef
Waiting for the changes after the adoption of steatotic liver disease Eileen L. Yoon, Dae Won Jun Clinical and Molecular Hepatology.2023; 29(4): 844. CrossRef
Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean? Eugene Han, Yong-ho Lee Clinical and Molecular Hepatology.2023; 29(4): 980. CrossRef
Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity Hong-Kyu Kim, Sung-Jin Bae, Min Jung Lee, Eun Hee Kim, Hana Park, Hwi Seung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee, Jaewon Choe Clinical and Molecular Hepatology.2023; 29(4): 987. CrossRef
What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease? Katarzyna Ferenc, Sara Jarmakiewicz-Czaja, Rafał Filip Life.2023; 14(1): 37. CrossRef
PCDH7 as the key gene related to the co-occurrence of sarcopenia and osteoporosis Mingchong Liu, Yongheng Wang, Wentao Shi, Chensong Yang, Qidong Wang, Jingyao Chen, Jun Li, Bingdi Chen, Guixin Sun Frontiers in Genetics.2023;[Epub] CrossRef
Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis” Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim Clinical and Molecular Hepatology.2023; 29(1): 173. CrossRef
Background/Aims Sarcopenia negatively affects the prognosis of cirrhotic patients, but clinical implications of changes in muscle mass remain unclear. We aimed to elucidate its role in the prognosis of outpatients with cirrhosis.
Methods Patients with cirrhosis who underwent annual abdominal computed tomography (CT) for hepatocellular carcinoma surveillance were included in the prospective cohort. The L3 skeletal muscle index (SMI) was adopted as a proxy for the amount of skeletal muscle, and the rate of SMI change between inclusion and after 1 year (ΔSMI/yr%) was calculated.
Results In total, 595 patients underwent a second CT after 1 year. Among them, 109 and 64 patients had sarcopenia and Child-Pugh class B/C decompensation at inclusion, which changed to 103 and 45 at the 1-year follow-up, respectively. During a median follow-up of 30.1 months after 1 year, 86 patients had at least one cirrhosis complication, and 18 died or received liver transplantation. In the development of cirrhosis complications, ΔSMI/yr% was independently associated, even after adjusting for the Child-Pugh and model for end stage liver disease (MELD)-Na scores. In addition, ΔSMI/yr% showed a good predictive performance for the development of cirrhosis complications within 6 months after 1-year follow-up in all subgroups, with a cut-off of -2.62 (sensitivity, 83.9%; specificity, 74.5%) in the overall population. SMI at 1-year and Child-Pugh score were independent factors associated with survival. In addition, changes in sarcopenia status significantly stratified survival.
Conclusion ΔSMI/yr% was a good predictor of the development of cirrhosis complications in outpatients with cirrhosis, independent of Child-Pugh and MELD scores.
Citations
Citations to this article as recorded by
Impact of year-to-year changes in skeletal muscle mass on the prediction of long-term survival in patients with liver cirrhosis Fulian Zhao, Ruojing Wang, Chengbin Zhu, Chang Zhang, Tianzhi Ni, Qijuan Zang, Yali Feng, Mengmeng Zhang, Li Zhu, Yage Zhu, Juan Du, Zhe Jiao, Chenxia Li, Taotao Yan, Yingli He, Yuchao Wu, Yingren Zhao, Yuan Yang Nutrition.2026; 142: 112982. CrossRef
Effect of adipose-related parameters on mortality in patients with liver cirrhosis: a meta-analysis Zhang Wen, Shuyue Tuo, Qiuju Ran, Jia Yuan, Yong Li, Ying Zhang, Danyan Chang, Chan Li, Shejiao Dai, Jinhai Wang, Xinxing Tantai Annals of Medicine.2025;[Epub] CrossRef
Assessment of Sarcopenia in Patients with Liver Cirrhosis—A Literature Review Dorotea Bozic, Bisera Mamic, Iva Peric, Ivona Bozic, Ivan Zaja, Tomislav Ivanovic, Ana Gugic Ratkovic, Ivica Grgurevic Nutrients.2025; 17(16): 2589. CrossRef
Predictive performance of distinct skeletal muscle index cut-offs-defined sarcopenia for long-term mortality in decompensated cirrhosis: A prospective observational study Chao Sun, Han Wang, Ziyi Yang, Huanli Jiao European Journal of Radiology.2025; 192: 112396. CrossRef
Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis Shuyue Tuo, Yee Hui Yeo, Rachel Chang, Zhang Wen, Qiuju Ran, Longbao Yang, Qing Fan, Junxiu Kang, Jiaojiao Si, Yi Liu, Haitao Shi, Yong Li, Jia Yuan, Na Liu, Shejiao Dai, Xiaoyan Guo, Jinhai Wang, Fanpu Ji, Xinxing Tantai Clinical Nutrition.2024; 43(1): 84. CrossRef
Correlation between sarcopenia and cirrhosis: a meta-analysis Yifan Cui, Mingming Zhang, Jing Guo, Jin Jin, Haijiao Wang, Xinran Wang Frontiers in Nutrition.2024;[Epub] CrossRef
Sarcopenia increases mortality risk in liver transplantation: a systematic review and meta-analysis Konstantinos PROKOPIDIS, Marco AFFRONTI, Giuseppe D. TESTA, Andrea UNGAR, Emanuele CEREDA, Lee SMITH, Francesco PEGREFFI, Mario BARBAGALLO, Nicola VERONESE Panminerva Medica.2024;[Epub] CrossRef
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis Elton Dajti, Susana G. Rodrigues, Federica Perazza, Luigi Colecchia, Giovanni Marasco, Matteo Renzulli, Giovanni Barbara, Francesco Azzaroli, Annalisa Berzigotti, Antonio Colecchia, Federico Ravaioli JHEP Reports.2024; 6(8): 101113. CrossRef
Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities Eugene Han, Yong-ho Lee, Sang Hoon Ahn, Bong-Soo Cha, Seung Up Kim, Byung-Wan Lee Gut and Liver.2024; 18(3): 509. CrossRef
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis Tatsunori Hanai, Kayoko Nishimura, Shinji Unome, Takao Miwa, Yuki Nakahata, Kenji Imai, Atsushi Suetsugu, Koji Takai, Masahito Shimizu Journal of Gastroenterology.2024; 59(10): 932. CrossRef
Muscle mass dynamics is independently associated with long-term liver-related mortality in patients with cirrhosis Jiarui Zheng, Shuo Yang, Wenhui Ren, Juan Zhong, Xin Liu, Rui Han, Tingyang Wei, Changjie Tie, Yuteng Yang, Chengwu Hong, Bo Feng, Rui Huang Heliyon.2024; 10(15): e35354. CrossRef
Accelerated muscle mass estimation from CT images through transfer learning Seunghan Yoon, Tae Hyung Kim, Young Kul Jung, Younghoon Kim BMC Medical Imaging.2024;[Epub] CrossRef
Psoas muscle index in sarcopenia following transjugular intrahepatic portosystemic shunt: A multicenter, retrospective study Tongqiang Li, Ze Wang, Yang Liu, Liguo Dai, Xiaoli Zhu, Jiacheng Liu, Qikun Guo, Weijie Luo, Yaowei Bai, Wei Luo, Menglan Chu, Duiping Feng, Bin Xiong Portal Hypertension & Cirrhosis.2024; 3(4): 173. CrossRef
Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis” Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim Clinical and Molecular Hepatology.2023; 29(1): 173. CrossRef
Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis” Do Seon Song, U Im Chang, Jin Mo Yang Clinical and Molecular Hepatology.2023; 29(1): 165. CrossRef
Interaction between sarcopenia and nonalcoholic fatty liver disease Sae Kyung Joo, Won Kim Clinical and Molecular Hepatology.2023; 29(Suppl): S68. CrossRef
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study Eugene Han, Ho Soo Chun, Yong‐ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Sang Hoon Ahn, Seung Up Kim Journal of Gastroenterology and Hepatology.2023; 38(9): 1598. CrossRef
Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin World Journal of Gastroenterology.2023; 29(27): 4236. CrossRef
Pretransplant Functional Status Predicts Postoperative Morbidity and Mortality after Liver Transplantation in Patients with Cirrhosis Myung Ji Goh, Jihye Kim, Won Hyuk Chang, Dong Hyun Sinn, Geum-Yeon Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Jong Man Kim, Wonseok Kang Gut and Liver.2023; 17(5): 786. CrossRef
Background/Aims Sarcopenia is an independent prognostic factor of liver cirrhosis (LC). However, the association between LC-related systemic inflammation and sarcopenia is unclear.
Methods Sprague-Dawley rats were treated with thioacetamide (TAA) or saline as a control. Rifaximin was administered to TAA-induced LC rats. Enzyme-linked immunosorbent assay was performed to measure inflammatory mediators in rat serum. RT-PCR was performed to measure the molecular expression in tissues. Hematoxylin and eosin (H&E) staining and immunohistochemistry were performed to investigate tissue pathology. Serum tumor necrosis factor-α levels, liver stiffness (LS), and the L3 skeletal muscle index (L3SMI) were measured in 60 patients with chronic liver disease.
Results LC and sarcopenia were successfully induced by TAA. Serum TNF-α levels were increased in LC rats and correlated with myostatin expression, muscle weight, and myofiber diameter. The expression of intestinal occludin and zona occludens-1 was reduced in LC rats and associated with serum TNF-α levels and sarcopenia. In patients with LS ≥7 kPa or sarcopenia, serum TNF-α levels were significantly increased, which was also confirmed when we raised the LS cutoff to 10 kPa. The L3SMI was inversely correlated with serum TNF-α levels in patients with LS ≥7 kPa. TNF-α was reduced by rifaximin, which might have resulted in reduced expression of muscular MuRF1 and myostatin and improvements in myofiber diameters within muscle tissues.
Conclusions These results suggest that serum TNF-α is associated with LC-related sarcopenia. Rifaximin might be effective in reducing serum TNF-α levels and improving sarcopenia in LC, but these results need to be validated in future studies.
Citations
Citations to this article as recorded by
New nomenclature and subclassification of steatotic liver disease and loss of skeletal muscle mass: A longitudinal cohort study Aryoung Kim, Danbee Kang, Sung Chul Choi, Dong Hyun Sinn, Geum‐Youn Gwak Hepatology Research.2025; 55(3): 373. CrossRef
Sarcopenia is associated with new-onset acute biliary infection within 1 year in patients with hepatitis B virus-related decompensated cirrhosis Shuangshuang Zhang, Tian Zhou, Mingbo Wu, Xuanxuan Xiong European Journal of Gastroenterology & Hepatology.2025; 37(1): 100. CrossRef
Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct‐acting antivirals Tomoyuki Suehiro, Hideko Kozuru, Kosuke Matusmoto, Yuki Kugiyama, Yasuhide Motoyoshi, Akira Saeki, Shinya Nagaoka, Kazumi Yamasaki, Atsumasa Komori, Hiroshi Yatsuhashi Hepatology Research.2025; 55(5): 631. CrossRef
Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States Fan Zhang, Longgen Liu, Wenjian Li Nutrition Journal.2025;[Epub] CrossRef
Cirrhosis Promotes Cardiac Fibrosis Development by Inhibiting Notch1 in Cardiac Fibroblasts He Sun, Kai Song, Ze-Yu Zhou, Bin Tu, Yang Zhou, Li-Chan Lin, Zhi-Yan Liu, Zhen-Yu Liu, Ji-Ming Sha, Yan Shi, Jing-Jing Yang, Dong Lu, Jian-Yuan Zhao, Hui Tao JACC: Basic to Translational Science.2025; 10(5): 612. CrossRef
Rifaximin-α use is associated with improved muscle mass in patients with cirrhosis Thomas Worland, Penelope Hey, Darren Wong, Ross Apostolov, Roseanne Kimberley Chan, Marie Sinclair, Paul Gow World Journal of Hepatology.2025;[Epub] CrossRef
Association of sarcopenia and physical activity on the severity of metabolic dysfunction-associated steatotic liver disease among United States adults: NHANES 2017 - 2018 Xiaodie Wei, Xiaohui Liu, Jinhan Zhao, Yang Zhang, Lixia Qiu, Jing Zhang Frontiers in Aging.2025;[Epub] CrossRef
Steatotic liver disease is a marker of multimorbidity, not underlying cirrhosis, in older adults O. Oduwole, C. Ding, N. Bitar, D. Nair, S. Salter, M. Silverman, R. Allen, L. Ng Fat, E. Tsochatzis, S. Bell, G. Mehta, A. Britton npj Gut and Liver.2025;[Epub] CrossRef
Peripheral blood inflammatory score using a cytokine multiplex assay predicts clinical outcomes in patients treated with atezolizumab-bevacizumab for unresectable HCC Hee Sun Cho, Soon Kyu Lee, Ji Won Han, Jung Hyun Kwon, Soon Woo Nam, Jaejun Lee, Keungmo Yang, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Jong Young Choi Frontiers in Immunology.2025;[Epub] CrossRef
Rifaximin and sarcopenia in cirrhosis: Commentary on a promising but complex relationship Mohamed El-Kassas, Khalid AlNaamani World Journal of Hepatology.2025;[Epub] CrossRef
Impact of low preoperative appendicular skeletal muscle mass on postoperative complications and short-term outcomes in liver transplant recipients: a propensity score-matched retrospective study Jing Xu, Qian Wu, Xiaofeng Xu, Feihong Weng, Tao Lv, Jian Yang, Shouping Wang, Rui Li, Chengbo Ai, Gang Xu, Lvnan Yan, Jiayin Yang Frontiers in Surgery.2025;[Epub] CrossRef
Nutritional screening and assessment tools for patients with cirrhosis based on the Global Leadership Initiative on Malnutrition criteria Yumei He, Ling Hu, Shiyan Wu, Lu Li, Ke Zhong, Jiazhen Li, Na Liu, Xiaobin Sun, Qiong Wang, Chao Sun, Liping Wu Journal of Human Nutrition and Dietetics.2024; 37(2): 430. CrossRef
Screening and assessment of malnutrition in patients with liver cirrhosis Yumei He, Zhiming Wang, Shiyan Wu, Lu Li, Jiazhen Li, Yexing Zhang, Boshi Chen, Xiaobin Sun, Chao Sun, Liping Wu Frontiers in Nutrition.2024;[Epub] CrossRef
Bibliometrics and knowledge mapping of the pathogenesis of hepatic encephalopathy in patients with liver cirrhosis Shiyan Wu, Lu Li, Heng Xi, Xiaoping Wu, Yumei He, Xiaobin Sun, Liping Wu Heliyon.2024; 10(15): e34330. CrossRef
Unraveling the mechanisms of hepatogenous diabetes and its therapeutic perspectives Manisha Yadav, Smriti Verma, Purnima Tiwari, Madhav Nilakanth Mugale Life Sciences.2024; 353: 122934. CrossRef
The Interplay Between Depression, Probiotics, Diet, Immunometabolic Health, the Gut, and the Liver—A Secondary Analysis of the Pro-Demet Randomized Clinical Trial Oliwia Gawlik-Kotelnicka, Jakub Rogalski, Karolina H. Czarnecka-Chrebelska, Jacek Burzyński, Paulina Jakubowska, Anna Skowrońska, Dominik Strzelecki Nutrients.2024; 16(23): 4024. CrossRef
Effects of Alnus japonica Hot Water Extract and Oregonin on Muscle Loss and Muscle Atrophy in C2C12 Murine Skeletal Muscle Cells Da Hyeon An, Chan Ho Lee, Yeeun Kwon, Tae Hee Kim, Eun Ji Kim, Jae In Jung, Sangil Min, Eun Ju Cheong, Sohyun Kim, Hee Kyu Kim, Sun Eun Choi Pharmaceuticals.2024; 17(12): 1661. CrossRef
Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis” Do Seon Song, U Im Chang, Jin Mo Yang Clinical and Molecular Hepatology.2023; 29(1): 165. CrossRef
Interaction between sarcopenia and nonalcoholic fatty liver disease Sae Kyung Joo, Won Kim Clinical and Molecular Hepatology.2023; 29(Suppl): S68. CrossRef
Sarcopenia in cirrhosis: epidemiology, diagnosis, management and prognosis Yi Liu, Fanpu Ji, Mindie H. Nguyen Current Opinion in Gastroenterology.2023; 39(3): 131. CrossRef
RETRACTED: Sinapic Acid Attenuate Liver Injury by Modulating Antioxidant Activity and Inflammatory Cytokines in Thioacetamide-Induced Liver Cirrhosis in Rats Ahmed Jabbar, Zaenah Alamri, Mahmood Abdulla, Ahmed AlRashdi, Soran Najmaldin, Mustafa Zainel Biomedicines.2023; 11(5): 1447. CrossRef
The Accuracy of Ultrasound Controlled Attenuation Parameter in Diagnosing Hepatic Fat Content Sebastiana Atzori, Yasmin Pasha, James B Maurice, Simon D Taylor-Robinson, Louise Campbell, Adrian KP Lim Hepatic Medicine: Evidence and Research.2023; Volume 15: 51. CrossRef
Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin World Journal of Gastroenterology.2023; 29(27): 4236. CrossRef
Skeletal muscle fibre morphology in childhood—insights into myopenia in pediatric liver disease Amber Hager, Vera Mazurak, Michelle Noga, Susan M. Gilmour, Diana R. Mager Applied Physiology, Nutrition, and Metabolism.2023; 48(10): 730. CrossRef
What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease? Katarzyna Ferenc, Sara Jarmakiewicz-Czaja, Rafał Filip Life.2023; 14(1): 37. CrossRef
Hematological and biochemical investigations on the effect of curcumin and Thymoquinone in male mice exposed to Thioacetamide Atef M. Al-Attar Saudi Journal of Biological Sciences.2022; 29(1): 660. CrossRef
A Review of Sarcopenia Pathophysiology, Diagnosis, Treatment and Future Direction Myung-Rae Cho, Sungho Lee, Suk-Kyoon Song Journal of Korean Medical Science.2022;[Epub] CrossRef
Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis Takumi Kawaguchi, Takuji Torimura Clinical and Molecular Hepatology.2022; 28(2): 177. CrossRef
Serum Myostatin among Excessive Drinkers Candelaria Martín-González, Onán Pérez-Hernández, Alen García-Rodríguez, Pedro Abreu-González, Paula Ortega-Toledo, Camino María Fernández-Rodríguez, Julio César Alvisa-Negrín, Antonio Martínez-Riera, Emilio González-Reimers International Journal of Molecular Sciences.2023; 24(3): 2981. CrossRef
Association between Regional Body Muscle Mass and Non-Alcoholic Fatty Liver Disease: An Observational Study Using Data from the REACTION Study Jing Du, Shizhan Ma, Li Fang, Meng Zhao, Zhongshang Yuan, Yiping Cheng, Jiajun Zhao, Xiude Fan, Qingling Guo, Zhongming Wu Journal of Personalized Medicine.2023; 13(2): 209. CrossRef
Interaction between sarcopenia and nonalcoholic fatty liver disease Sae Kyung Joo, Won Kim Clinical and Molecular Hepatology.2023; 29(Suppl): S68. CrossRef
Lack of association between serum myonectin levels and sarcopenia in older Asian adults Sunghwan Ji, So Jeong Park, Jin Young Lee, Ji Yeon Baek, Hee-Won Jung, Kyunggon Kim, Hyun Ju Yoo, Il-Young Jang, Beom-Jun Kim Experimental Gerontology.2023; 178: 112229. CrossRef
Computed tomography‐determined skeletal muscle density predicts 3‐year mortality in initial‐dialysis patients in China Ming‐jie Sheng, Jing‐yuan Cao, Shi‐mei Hou, Min Li, Yao Wang, Qiang Fang, A‐feng Miao, Min Yang, Shu‐su Liu, Chun‐hong Hu, Cui‐lan Liu, Shi‐yuan Wang, Jing Zheng, Jing‐jie Xiao, Xiao‐liang Zhang, Hong Liu, Bi‐cheng Liu, Bin Wang Journal of Cachexia, Sarcopenia and Muscle.2023; 14(6): 2569. CrossRef
Regulator 1-Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α Signaling Pathway in Investigating the Pathological Characteristics and Molecular Mechanism of Liver Cirrhosis Complicated by Acute Kidney Injury Jieqi Gong, Huanhua Lu Journal of Biomaterials and Tissue Engineering.2022; 12(1): 112. CrossRef
Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song Clinical and Molecular Hepatology.2022; 28(2): 219. CrossRef
Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis Takumi Kawaguchi, Takuji Torimura Clinical and Molecular Hepatology.2022; 28(2): 177. CrossRef
Viral eradication by direct-acting antivirals does not decrease the serum myostatin level in patients infected with hepatitis C virus Kei Endo, Takuro Sato, Yuichi Yoshida, Keisuke Kakisaka, Akio Miyasaka, Yasuhiro Takikawa Nutrition.2022; 101: 111699. CrossRef
Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman Journal of Cellular Biochemistry.2022; 123(10): 1553. CrossRef
Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim Cancers.2021; 13(14): 3424. CrossRef
Background/Aims The role of serum myokine levels in sarcopenia and the outcome of hepatocellular carcinoma (HCC) patients are not clear. This study investigated the serum levels of myostatin, follistatin, and interleukin-6 (IL-6) in HCC patients and their association with sarcopenia and survival.
Methods Using prospectively collected pretreatment samples from 238 HCC patients in a hospital from 2012 to 2015, the serum levels of 3 myokines were determined and compared to 50 samples from age and sex-matched healthy controls. Sarcopenia was evaluated using the psoas muscle index (PMI) measured at the third lumbar level in the computed tomography, and clinical data were collected until 2017.
Results The median levels of the 3 myokines for the male and female HCC patients were as follow: myostatin (3,979.3 and 2,976.3 pg/mL), follistatin (2,118.5 and 2,174.6 pg/mL), and IL-6 (2.5 and 2.7 pg/mL), respectively. Those in the HCC patients were all significantly higher than in the healthy controls. In the HCC patient, the median PMI was 4.43 (males) and 2.17 cm2/m2 (females) with a sarcopenic prevalence of 56.4%. The serum levels of myostatin, IL-6 and follistatin in the HCC patients showed a positive, negative, and no correlation with PMI, respectively. The serum follistatin level was an independent factor for poor survival in HCC patients.
Conclusions The serum levels of myostatin, follistatin, and IL-6 and their correlation with sarcopenia and survival were presented in HCC patients for the first time. The role of the serum follistatin level as a poor prognostic biomarker warrants further study.
Citations
Citations to this article as recorded by
The Role of Myokines in Liver Diseases Hiroki Nishikawa, Soo Ki Kim, Akira Asai International Journal of Molecular Sciences.2025; 26(3): 1043. CrossRef
Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct‐acting antivirals Tomoyuki Suehiro, Hideko Kozuru, Kosuke Matusmoto, Yuki Kugiyama, Yasuhide Motoyoshi, Akira Saeki, Shinya Nagaoka, Kazumi Yamasaki, Atsumasa Komori, Hiroshi Yatsuhashi Hepatology Research.2025; 55(5): 631. CrossRef
The emerging role of exercise preconditioning in preventing skeletal muscle atrophy Xu Zhou, Shiming Li, Lu Wang, Jun Wang, Peng Zhang, Xiaoping Chen Frontiers in Physiology.2025;[Epub] CrossRef
New insights into biomarkers and risk stratification to predict hepatocellular cancer Katrina Li, Brandon Mathew, Ethan Saldanha, Puja Ghosh, Adrian R. Krainer, Srinivasan Dasarathy, Hai Huang, Xiyan Xiang, Lopa Mishra Molecular Medicine.2025;[Epub] CrossRef
The association between shorter disease course and sarcopenia in women with endometriosis: a retrospective analysis of NHANES 1999–2006 Litao Sun, Yishu Tian, Lei Ling Scientific Reports.2025;[Epub] CrossRef
State-of-the-art insights into myokines as biomarkers of sarcopenia: a literature review Omar R Moussaoui International Journal of Physiology, Pathophysiology and Pharmacology.2025; 17(3): 80. CrossRef
Myokine Circulating Levels in Postmenopausal Women with Overweight or Obesity: Effects of Resistance Training and/or DHA-Rich n-3 PUFA Supplementation Alejandro Martínez-Gayo, Elisa Félix-Soriano, Javier Ibáñez-Santos, Marisol García-Unciti, Pedro González-Muniesa, María J. Moreno-Aliaga Nutrients.2025; 17(15): 2553. CrossRef
Exerkines and myokines in aging sarcopenia Huan Wang, Wenbi He, Peishan Chen, Haozhe Wang, Huiguo Wang, Lin Zhu, Xiaoguang Liu Frontiers in Endocrinology.2025;[Epub] CrossRef
Alpha‐Ketoisocaproate Attenuates Muscle Atrophy in Cancer Cachexia Models Pooreum Lim, Sang Woo Woo, Jihye Han, Young Lim Lee, Jin Ju Lim, Yeong Hoon Kang, Ji Wook Moon, Jeong Min Nam, Jeong Hyeon Kim, Donghun Kim, Jae Ho Shim, Hyeon Soo Kim Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub] CrossRef
Associations Among Skeletal Muscle Mass, Bone Mineral Density, and Cardiometabolic Risk Factors in Young and Middle-Aged Adults Yeonhwi Kim, Minje Ji, Sewon Lee Exercise Science.2025; 34(3): 308. CrossRef
Alterations in the Myokine Concentrations in Relation to Sarcopenia and Sleep Disturbances: A Narrative Review Michalina Knapik, Jakub Kuna, Grzegorz Chmielewski, Łukasz Jaśkiewicz, Magdalena Krajewska-Włodarczyk Journal of Clinical Medicine.2025; 14(18): 6527. CrossRef
A non-invasive decision tree predicting recurrence-free survival after liver transplantation for hepatocellular carcinoma Mo- Dan Yang, Jian-Yong Zhuo, Guo-Ying Wang, Li Zhuang, Xiao Xu, Shu-Sen Zheng, Yang Yang, Di Lu Hepatobiliary & Pancreatic Diseases International.2025;[Epub] CrossRef
Diabetes Mellitus Should Be Considered While Analysing Sarcopenia-Related Biomarkers Justyna Rentflejsz, Zyta Beata Wojszel Journal of Clinical Medicine.2024; 13(4): 1107. CrossRef
Myostatin and Activin A as Biomarkers of Sarcopenia in Inflammatory Bowel Disease Patients Małgorzata Godala, Ewelina Gaszyńska, Konrad Walczak, Ewa Małecka-Wojciesko Nutrients.2024; 16(6): 810. CrossRef
Hepatocellular carcinoma and musculoskeletal system: A narrative literature review Jelena Jadzic, Danijela Djonic World Journal of Gastroenterology.2024; 30(15): 2109. CrossRef
Role of Myostatin in Rheumatoid Arthritis: A Review of the Clinical Impact Fabiola Gonzalez-Ponce, Melissa Ramirez-Villafaña, Eli Efrain Gomez-Ramirez, Ana Miriam Saldaña-Cruz, Sergio Gabriel Gallardo-Moya, Norma Alejandra Rodriguez-Jimenez, Heriberto Jacobo-Cuevas, Cesar Arturo Nava-Valdivia, Felipe Alexis Avalos-Salgado, Sylvi Diagnostics.2024; 14(11): 1085. CrossRef
Exploring the impact of interleukins on sarcopenia development: A systematic review and meta-analysis Yan He, Wenrong Duan, Ping Xu, Taiping Lin, Qiao Xiang, Birong Dong, Ning Ge, Jirong Yue Experimental Gerontology.2024; 193: 112480. CrossRef
Circulating myostatin as a biomarker of muscle mass and strength in individuals with cancer or obesity Laura Orioli, Sofia Samaras, Kiswendsida Sawadogo, Marie de Barsy, Pascale Lause, Yannick Deswysen, Benoit Navez, Jean-Paul Thissen, Audrey Loumaye Clinical Nutrition.2024; 43(7): 1800. CrossRef
Follistatin-respiratory connection predicting all-cause mortality among community-dwelling middle-to-old age individuals: Results from the I-Lan Longitudinal Study Hsiao-Chin Shen, Wei-Ju Lee, Chuan-Yen Sun, Wen-Kuang Yu, Wei-Chih Chen, Fei-Yuan Hsiao, Kuang-Yao Yang, Liang-Kung Chen The Journal of nutrition, health and aging.2024; 28(8): 100285. CrossRef
Epigenetics of Skeletal Muscle Atrophy Jiacheng Du, Qian Wu, Eun Ju Bae International Journal of Molecular Sciences.2024; 25(15): 8362. CrossRef
Chitinase-3 like-protein-1, a prognostic biomarker in patients with hepatocellular carcinoma and concomitant myosteatosis Chiyu He, Zhihang Hu, Zuyuan Lin, Hao Chen, Chenghao Cao, Jinyan Chen, Xudong Yang, Huigang Li, Wei Shen, Xuyong Wei, Li Zhuang, Shusen Zheng, Xiao Xu, Di Lu BMC Cancer.2024;[Epub] CrossRef
Association of interleukin-6 with sarcopenia and its components in older adults: a systematic review and meta-analysis of cross-sectional studies Jie Ding, Guangyue Yang, Wen Sun, Yifei Li, Ning Wang, Jiening Wang, Yongfang Zhao Annals of Medicine.2024;[Epub] CrossRef
NADPH oxidase 4 deficiency promotes hepatocellular carcinoma arising from hepatic fibrosis by inducing M2-macrophages in the tumor microenvironment Ji Young Kim, Wonseok Kang, Sera Yang, Su Hyun Park, Sang Yun Ha, Yong-Han Paik Scientific Reports.2024;[Epub] CrossRef
Textbook outcomes of hepatocellular carcinoma patients with sarcopenia: A multicenter analysis Di-Hang Wu, Cheng-Yu Liao, Dan-Feng Wang, Long Huang, Ge Li, Jiang-Zhi Chen, Liang Wang, Tian-Sheng Lin, Jian-Lin Lai, Song-Qiang Zhou, Fu-Nan Qiu, Zhi-Bo Zhang, Yan-Ling Chen, Yao-Dong Wang, Xiao-Chun Zheng, Yi-Feng Tian, Shi Chen European Journal of Surgical Oncology.2023; 49(4): 802. CrossRef
Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis” Do Seon Song, U Im Chang, Jin Mo Yang Clinical and Molecular Hepatology.2023; 29(1): 165. CrossRef
Association between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma: an updated meta-analysis Yusheng Guo, Yanqiao Ren, Licheng Zhu, Lian Yang, Chuansheng Zheng Scientific Reports.2023;[Epub] CrossRef
Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts Yunjian Wu, Kimberley C. Clark, Birunthi Niranjan, Anderly C. Chüeh, Lisa G. Horvath, Renea A. Taylor, Roger J. Daly Molecular Oncology.2023; 17(3): 469. CrossRef
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment Anne-Laure Couderc, Evelyne Liuu, Pascaline Boudou-Rouquette, Johanne Poisson, Maxime Frelaut, Coline Montégut, Soraya Mebarki, Romain Geiss, Zoé ap Thomas, Aurélien Noret, Monica Pierro, Capucine Baldini, Elena Paillaud, Frédéric Pamoukdjian Nutrients.2023; 15(5): 1193. CrossRef
Interaction between sarcopenia and nonalcoholic fatty liver disease Sae Kyung Joo, Won Kim Clinical and Molecular Hepatology.2023; 29(Suppl): S68. CrossRef
Review article: Putting some muscle into sarcopenia—the pathogenesis, assessment and clinical impact of muscle loss in patients with inflammatory bowel disease Stephanie L. Gold, Maitreyi Raman, Bruce E. Sands, Ryan Ungaro, João Sabino Alimentary Pharmacology & Therapeutics.2023; 57(11): 1216. CrossRef
Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients Andrea Dalbeni, Leonardo Antonio Natola, Marta Garbin, Mirko Zoncapè, Filippo Cattazzo, Anna Mantovani, Antonio Vella, Stefania Canè, Jasmin Kassem, Michele Bevilacqua, Simone Conci, Tommaso Campagnaro, Andrea Ruzzenente, Alessandra Auriemma, Alessandro D Cancers.2023; 15(9): 2406. CrossRef
Prevalence of sarcopenia among patients with hepatocellular carcinoma: A systematic review and meta‑analysis Jiye Liu, Hanyong Luo, Letian Huang, Jiahe Wang Oncology Letters.2023;[Epub] CrossRef
Highlighting the idea of exerkines in the management of cancer patients with cachexia: novel insights and a critical review Amirhossein Ahmadi Hekmatikar, André Nelson, Aaron Petersen BMC Cancer.2023;[Epub] CrossRef
Metabolic crosstalk between skeletal muscle cells and liver through IRF4-FSTL1 in nonalcoholic steatohepatitis Shanshan Guo, Yonghao Feng, Xiaopeng Zhu, Xinyi Zhang, Hui Wang, Ruwen Wang, Qiongyue Zhang, Yiming Li, Yan Ren, Xin Gao, Hua Bian, Tiemin Liu, Huanqing Gao, Xingxing Kong Nature Communications.2023;[Epub] CrossRef
Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis Xuanmei Li, Xue Huang, Lifu Lei, Shiwen Tong Frontiers in Nutrition.2023;[Epub] CrossRef
Muscle-bone crosstalk via endocrine signals and potential targets for osteosarcopenia-related fracture Renwang Sheng, Mumin Cao, Mingyuan Song, Mingyue Wang, Yuanwei Zhang, Liu Shi, Tian Xie, Yingjuan Li, Jinyu Wang, Yunfeng Rui Journal of Orthopaedic Translation.2023; 43: 36. CrossRef
Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions Abhilash Perisetti, Hemant Goyal, Rachana Yendala, Saurabh Chandan, Benjamin Tharian, Ragesh Babu Thandassery World Journal of Gastroenterology.2022; 28(4): 432. CrossRef
Interleukin-6 Induced Proliferation Is Attenuated by Transforming Growth Factor-β-Induced Signaling in Human Hepatocellular Carcinoma Cells Abhilasha Srivastava, Harshita Sharma, Simran Khanna, Tejasvini Sadhu Balasundaram, Shibasish Chowdhury, Rajdeep Chowdhury, Sudeshna Mukherjee Frontiers in Oncology.2022;[Epub] CrossRef
Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis Takumi Kawaguchi, Takuji Torimura Clinical and Molecular Hepatology.2022; 28(2): 177. CrossRef
Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song Clinical and Molecular Hepatology.2022; 28(2): 219. CrossRef
Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy Myung Ji Goh, Wonseok Kang, Woo Kyoung Jeong, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik Scientific Reports.2022;[Epub] CrossRef
A Review of Sarcopenia Pathophysiology, Diagnosis, Treatment and Future Direction Myung-Rae Cho, Sungho Lee, Suk-Kyoon Song Journal of Korean Medical Science.2022;[Epub] CrossRef
Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman Journal of Cellular Biochemistry.2022; 123(10): 1553. CrossRef
Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma Hiroaki Matsumoto, Kaoru Tsuchiya, Hiroyuki Nakanishi, Yuka Hayakawa, Yutaka Yasui, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Shun Ishido, Michiko Yamada, Taisei Keitoku, Tsubasa Nobusawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chia Cancers.2022; 14(14): 3551. CrossRef
CT-based skeletal muscle loss for predicting poor survival in patients with hepatocellular carcinoma experiencing curative hepatectomy plus adjuvant transarterial chemoembolization: a preliminary retrospective study Siwei Yang, Zhiyuan Zhang, Tianhao Su, Jianan Yu, Shasha Cao, Haochen Wang, Long Jin European Journal of Medical Research.2022;[Epub] CrossRef
Computed tomography-measured body composition and survival in rectal cancer patients: a Swedish cohort study Angeliki Kotti, Annica Holmqvist, Mischa Woisetschläger, Xiao-Feng Sun Cancer & Metabolism.2022;[Epub] CrossRef
Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim, Joo Won Baik, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun Clinical and Molecular Hepatology.2022; 28(4): 876. CrossRef
What Is the Role of Body Composition Assessment in HCC Management? Pompilia Radu, Maryam Ebadi, Aldo J. Montano-Loza, Jean Francois Dufour Cancers.2022; 14(21): 5290. CrossRef
The effect of sarcopenia and serum myokines on prognosis and survival in cirrhotic patients: a multicenter cross-sectional study Salih Boga, Abdullah Emre Yildirim, Enver Ucbilek, Ali Riza Koksal, Sevil Tokdemir Sisman, Ibrahim Durak, Ilker Sen, Beril Dogu, Erdinc Serin, Ayse Bolat Ucbilek, Makbule Ozge Yildirim, Sukru Mehmet Erturk, Huseyin Alkim, Canan Alkim European Journal of Gastroenterology & Hepatology.2022; 34(12): 1261. CrossRef
Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis Chuan Jiang, Yanyan Wang, Wei Fu, Guozhuan Zhang, Xiaoshan Feng, Xing Wang, Fang Wang, Le Zhang, Yang Deng Frontiers in Nutrition.2022;[Epub] CrossRef
Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans Grigorios Panagiotou, Wael Ghaly, Jagriti Upadhyay, Kalliopi Pazaitou-Panayiotou, Christos S Mantzoros The Journal of Clinical Endocrinology & Metabolism.2021; 106(5): e2137. CrossRef
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123. CrossRef
High Visceral Adipose Tissue Density Correlates With Unfavorable Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Qiang Li, Lei Zhang, Zhong-Heng Hou, Dong-Xu Zhao, Jian-Bin Li, Shuai Zhang, Yu Yin, Cai-Fang Ni, Tao Chen Frontiers in Cell and Developmental Biology.2021;[Epub] CrossRef
Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women Yanping Du, Cuidi Xu, Hongli Shi, Xin Jiang, Wenjing Tang, Xiaoqing Wu, Minmin Chen, Huilin Li, Xuemei Zhang, Qun Cheng BMC Geriatrics.2021;[Epub] CrossRef
A Multifactorial Approach for Sarcopenia Assessment: A Literature Review Rashmi Supriya, Kumar Purnendu Singh, Yang Gao, Feifei Li, Frédéric Dutheil, Julien S. Baker Biology.2021; 10(12): 1354. CrossRef
Irisin in Liver Cirrhosis Michał Kukla, Lubomir Skladany, Tomasz Menżyk, Aleksandra Derra, Dominika Stygar, Magdalena Skonieczna, Dorota Hudy, Katarzyna Nabrdalik, Janusz Gumprecht, Wojciech Marlicz, Anastasios Koulaouzidis, Tomas Koller Journal of Clinical Medicine.2020; 9(10): 3158. CrossRef
Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma Sooyeon Oh, Jooho Lee Clinical and Molecular Hepatology.2020; 26(4): 476. CrossRef
Sarcopenia (loss of muscle mass and/or strength) frequently complicates liver cirrhosis and adversely affects the quality of life; cirrhosis related liver decompensation and significantly decreases wait-list and post-liver transplantation survival. The main therapeutic strategies to improve or reverse sarcopenia include dietary interventions (supplemental calorie and protein intake), increased physical activity (supervised resistance and endurance exercises), hormonal therapy (testosterone), and ammonia lowering agents (L-ornithine L-aspartate, branch chain amino acids) as well as mechanistic approaches that target underlying molecular and metabolic abnormalities. Besides other factors, hyperammonemia has recently gained attention and increase sarcopenia by various mechanisms including increased expression of myostatin, increased phosphorylation of eukaryotic initiation factor 2a, cataplerosis of α ketoglutarate, mitochondrial dysfunction, increased reactive oxygen species that decrease protein synthesis and increased autophagy-mediated proteolysis. Sarcopenia contributes to frailty and increases the risk of minimal and overt hepatic encephalopathy.
Citations
Citations to this article as recorded by
Transjugular Intrahepatic Portosystemic Shunt Related Hepatic Encephalopathy in Cirrhotics With Refractory Ascites: Incidence and Correlation With TIPS Stent Diameter and Pre-TIPS Sarcopenia Amar Mukund, Vritika Bhardwaj, Ankur Jindal, Yashwant Patidar, Shiv K. Sarin Journal of Clinical and Experimental Hepatology.2026; 16(1): 103125. CrossRef
Nutritional aspects of prehabilitation in adults with cirrhosis awaiting liver transplant Christofer Cruz, Carla M. Prado, Chelsia Gillis, Robert Martindale, Chantal Bémeur, Jennifer C. Lai, Puneeta Tandon Hepatology.2025; 82(6): 1582. CrossRef
Body Compositions Correlate With Overt Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Wenfeng Shi, Weiguo Xu, Ningning Fan, Yong Li, Xiaoqiong Chen, Yujie Zhao, Xiao Bai, Yang Yang Journal of Clinical Gastroenterology.2025; 59(3): 262. CrossRef
Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota Xiaotong Xu, Tong Zhu, Changyou Jing, Minjie Jiang, Yunlai Fu, Fang Xie, Qinghua Meng, Jianjun Li Frontiers in Medicine.2025;[Epub] CrossRef
The Molecular Pathogenesis of Sarcopenia/Frailty in Cirrhosis Huanli Jiao, Han Wang, Jia Li, Ziyi Yang, Chao Sun Seminars in Liver Disease.2025; 45(03): 303. CrossRef
Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions Ying Li, Yu-Tong Wu, Hao Wu World Journal of Gastroenterology.2025;[Epub] CrossRef
Biomedical identify the drugs between primary osteoporosis and sarcopenia Zhangxin Chen, Jianxing Lin, Zhengjin Wang Medicine.2025; 104(28): e42975. CrossRef
Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS Martin Andreas Kabelitz, Simon Johannes Gairing, Anja Tiede, Eva Maria Schleicher, Liv Grete Ahl, Lea Wagner, Falko Zucker‐Reimann, Hannah Rieland, Jim Benjamin Mauz, Julia Weinmann‐Menke, Bernhard C. Meyer, Michael Bernhard Pitton, Heiner Wedemeyer, Pete Alimentary Pharmacology & Therapeutics.2025;[Epub] CrossRef
Metabolic and immune links between sarcopenia and liver disease Stanislav Nikolaevich Kotlyarov World Journal of Hepatology.2025;[Epub] CrossRef
Current advances in the management of hepatic encephalopathy: an updated and critical review Bilal El-Mansoury, Hicham Esselmani, Mohamed Merzouki, Ezhilarasan Devaraj, Omar El Hiba, Arturo Ortega, Mustapha Najimi Pharmacological Reports.2025;[Epub] CrossRef
Multi-omics tests identify novel shared genetic mechanisms of primary biliary cholestasis and sarcopenia Zhonghai Wang, Meiling Yu, Han Wang Scientific Reports.2025;[Epub] CrossRef
Protein and Macronutrient Metabolism in Liver Cirrhosis: About Sarcopenia Seul Ki Han, Soon Koo Baik, Moon Young Kim Nutrients.2025; 17(21): 3346. CrossRef
Sarcopenia modelling by portal vein ligation inducing hyperammonemia in rats Maria Nadinskaia, Kseniya Gulyaeva, Aleksandr Sukhinin, Alla Sedova, Polina Boykova, Ilya Izmailov, Ksenia Pokidova, Egor Kuzmin, Artem Venediktov, Igor Meglinski, Gennadii Piavchenko, Erfan Ghadirzadeh PLOS One.2025; 20(11): e0337178. CrossRef
Age‐related impact of outcomes in hospitalized patients with alcohol overuse Dhweeja Dasarathy, Amy H. Attaway Alcohol, Clinical and Experimental Research.2025;[Epub] CrossRef
Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosis Eva Maria Schleicher, Leonard Kaps, Jörn M. Schattenberg, Peter Robert Galle, Marcus-Alexander Wörns, Simon Johannes Gairing, Christian Labenz Digestive and Liver Disease.2024; 56(6): 1046. CrossRef
The Application of Rifaximin in Patients with End Stage Liver Disease 皓月 田 Advances in Clinical Medicine.2024; 14(01): 466. CrossRef
Correlation between sarcopenia and cirrhosis: a meta-analysis Yifan Cui, Mingming Zhang, Jing Guo, Jin Jin, Haijiao Wang, Xinran Wang Frontiers in Nutrition.2024;[Epub] CrossRef
Impact of nutritional status on the outcome of transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review Suprabhat Giri, Prajna Anirvan, Mansi Chaudhary, Taraprasad Tripathy, Ranjan Kumar Patel, Mitali Madhumita Rath, Manas Kumar Panigrahi British Journal of Radiology.2024; 97(1154): 331. CrossRef
Implications of Protein and Sarcopenia in the Prognosis, Treatment, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Avneet Singh, Adam Buckholz, Sonal Kumar, Carolyn Newberry Nutrients.2024; 16(5): 658. CrossRef
Shining a spotlight on sarcopenia and myosteatosis in liver disease and liver transplantation Sophie Reichelt, Uta Merle, Miriam Klauss, Christoph Kahlert, Georg Lurje, Arianeb Mehrabi, Zoltan Czigany Liver International.2024; 44(7): 1483. CrossRef
Emerging drugs for the treatment of sarcopenia in cirrhosis of the liver Simone Di Cola, Saniya Khan, Lucia Lapenna, Manuela Merli Expert Opinion on Emerging Drugs.2024; 29(2): 81. CrossRef
The protein nutritional status affects hope of patients in the terminal phase of cancer Wojciech Kolanowski, Bożena Baczewska, Krzysztof Leśniewski Medical Hypotheses.2024; 186: 111337. CrossRef
Siroz ve Malnütrisyon Merve Şatay, Sevan Çetin, İlknur Gökçe Yıldırım Kastamonu Üniversitesi Sağlık Bilimleri Fakültesi Dergisi.2024; 3(1): 11. CrossRef
Sarcopenic obesity in patients awaiting liver transplant: Unique challenges for nutritional recommendations Darya M Herscovici, Katherine M Cooper, Alessandro Colletta, Michelle Rightmyer, Alexandra Shingina, Lauren D Feld World Journal of Transplantation.2024;[Epub] CrossRef
External validation of the modified CTP score based on ammonia to predict survival in patients with cirrhosis after TIPS placement Binlin Da, Wei Wu, Wuhua Guo, Kai Xiong, Chao Chen, Qiao Ke, Moran Zhang, Taishun Li, Jiangqiang Xiao, Lei Wang, Ming Zhang, Feng Zhang, Yuzheng Zhuge Scientific Reports.2024;[Epub] CrossRef
Beyond the Liver Jiannan Huang, Ibrahim Munaf Ahmed, Tian Wang, Chencheng Xie Clinics in Liver Disease.2024; 28(4): 681. CrossRef
The effects of Qingchang Ligan formula on hepatic encephalopathy in mouse model: results from gut microbiome-metabolomics analysis Ziwei Yang, Shuhui Liu, Feili Wei, Jianhua Hu Frontiers in Cellular and Infection Microbiology.2024;[Epub] CrossRef
The Value of Ammonia as a Biomarker in Patients with Cirrhosis Maria Pilar Ballester, Esra Nur Durmazer, Tingting Qi, Rajiv Jalan Seminars in Liver Disease.2024; 44(03): 356. CrossRef
S2k-Leitlinie Klinische Ernährung in der Hepatologie Mathias Plauth, Lars Bechmann, Donata Grajecki, Felix Gundling, Ludwig Kramer, Andreas E. Kremer, Monika Rau, Andrea Schneider, Frank Tacke, Ingo van Thiel Aktuelle Ernährungsmedizin.2024; 49(04): 256. CrossRef
Sarcopenia in cirrhosis: From pathophysiology to interventional therapy Huiling Chen, Chenyun Yang, Shijie Yan, Xintao Liu, Ligang Zhou, Xinlu Yuan Experimental Gerontology.2024; 196: 112571. CrossRef
Hyperammonaemic encephalopathy due to non-functioning urea cycle as a complication to gastric bypass surgery Kristoffer Kjærgaard, Peter Lykke Eriksen, Thomas Kromann Nøhr, Steen Bønløkke Pedersen, Claus Højbjerg Gravholt, Hendrik Vilstrup, Karen Louise Thomsen Metabolic Brain Disease.2024;[Epub] CrossRef
Increased rumen Prevotella enhances BCAA synthesis, leading to synergistically increased skeletal muscle in myostatin-knockout cattle Chao Hai, Zhenting Hao, Lige Bu, Jiaru Lei, Xuefei Liu, Yuefang Zhao, Chunling Bai, Guanghua Su, Lei Yang, Guangpeng Li Communications Biology.2024;[Epub] CrossRef
Sarcopenia in the Cirrhotic Patient: Current Knowledge and Future Directions Edgewood R. Warner II, Sanjaya K. Satapathy Journal of Clinical and Experimental Hepatology.2023; 13(1): 162. CrossRef
Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis” Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim Clinical and Molecular Hepatology.2023; 29(1): 173. CrossRef
Nutrition in Viral Hepatitis Dibya L. Praharaj, Anil C. Anand Current Hepatology Reports.2023; 22(1): 9. CrossRef
Enteral nutrition product formulations: A review of available products and indications for use April Church, Steph Zoeller Nutrition in Clinical Practice.2023; 38(2): 277. CrossRef
Sarcopenia and Frailty in Cirrhosis Chalermrat Bunchorntavakul Medical Clinics of North America.2023; 107(3): 589. CrossRef
Methionine adenosyltransferase2A inhibition restores metabolism to improve regenerative capacity and strength of aged skeletal muscle Nika Rajabian, Izuagie Ikhapoh, Shahryar Shahini, Debanik Choudhury, Ramkumar Thiyagarajan, Aref Shahini, Joseph Kulczyk, Kendall Breed, Shilpashree Saha, Mohamed Alaa Mohamed, Susan B. Udin, Aimee Stablewski, Kenneth Seldeen, Bruce R. Troen, Kirkwood Per Nature Communications.2023;[Epub] CrossRef
Breath-by-breath measurement of exhaled ammonia by acetone-modifier positive photoionization ion mobility spectrometry via online dilution and purging sampling Lu Wang, Dandan Jiang, Lei Hua, Chuang Chen, Dongming Li, Weiguo Wang, Yiqian Xu, Qimu Yang, Haiyang Li, Song Leng Journal of Pharmaceutical Analysis.2023; 13(4): 412. CrossRef
Quick surface adsorption and sensing of ammonia at room temperature by In2S3 thin films Sumit Kumar, Teny Theresa John Applied Surface Science.2023; 620: 156816. CrossRef
Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis Simon J. Gairing, Eva M. Schleicher, Peter R. Galle, Christian Labenz Hepatology Communications.2023;[Epub] CrossRef
Visión actual sobre el diagnóstico y los cuidados integrales en la encefalopatía hepática F. Higuera-de-la-Tijera, J.A. Velarde-Ruiz Velasco, R.H. Raña-Garibay, G.E. Castro-Narro, J.M. Abdo-Francis, R. Moreno-Alcántar, J.L. Pérez-Hernández, A. Torre, R. Contreras-Omaña, A. Cano-Contreras, M. Castillo-Barradas, J. Pérez-Escobar, J.M. Aldana-Led Revista de Gastroenterología de México.2023; 88(2): 155. CrossRef
Current vision on diagnosis and comprehensive care in hepatic encephalopathy F. Higuera-de-la-Tijera, J.A. Velarde-Ruiz Velasco, R.H. Raña-Garibay, G.E. Castro-Narro, J.M. Abdo-Francis, R. Moreno-Alcántar, J.L. Pérez-Hernández, A. Torre, R. Contreras-Omaña, A. Cano-Contreras, M. Castillo-Barradas, J. Pérez-Escobar, J.M. Aldana-Led Revista de Gastroenterología de México (English Edition).2023; 88(2): 155. CrossRef
A Prospective Study of Prevalence and Impact of Sarcopenia on Short-term Mortality in Hospitalized Patients with Liver Cirrhosis Surakshith Thyloor Kenchappa, Samarth Sharma, Mandhir Kumar, Samarjit S. Ghuman, Anil Arora, Piyush Ranjan Journal of Clinical and Experimental Hepatology.2023; 13(6): 946. CrossRef
A modified Child-Turcotte-Pugh score based on plasma ammonia predicts survival for patients with decompensated cirrhosis X Wang, M Zhang, J Xiao, W Zhang, Y Wang, S Zhang, X Zou, L Wang, Y Zhuge, F Zhang QJM: An International Journal of Medicine.2023; 116(6): 436. CrossRef
Potential Benefits of Epidermal Growth Factor for Inhibiting Muscle Degrative Markers in Rats with Alcoholic Liver Damage Qian Xiao, Yi-Hsiu Chen, Ya-Ling Chen, Yu-Shan Chien, Li-Hsuan Hsieh, Hitoshi Shirakawa, Suh-Ching Yang International Journal of Molecular Sciences.2023; 24(10): 8845. CrossRef
Sarcopenia in chronic viral hepatitis: From concept to clinical relevance Marta Paula Pereira Coelho, Pedro Alves Soares Vaz de Castro, Thaís Pontello de Vries, Enrico Antônio Colosimo, Juliana Maria Trindade Bezerra, Gifone Aguiar Rocha, Luciana Diniz Silva World Journal of Hepatology.2023; 15(5): 649. CrossRef
GDF8 Contributes to Liver Fibrogenesis and Concomitant Skeletal Muscle Wasting Alexander Culver, Matthew Hamang, Yan Wang, Huaizhou Jiang, Jennifer Yanum, Emily White, Samer Gawrieh, Raj K. Vuppalanchi, Naga P. Chalasani, Guoli Dai, Benjamin C. Yaden Biomedicines.2023; 11(7): 1909. CrossRef
Investigation of Changes in Skeletal Muscle Mass and Muscle Quality and Factors Affecting Changes in Deceased Donor Liver Transplantation Hirokazu Onishi, Ryo Yoshikawa, Risa Harada, Tsuyoshi Matsumoto, Tetsuro Kurashina, Akimasa Adachi, Yasumitsu Fujii, Kaori Kuramitsu, Takumi Fukumoto, Yoshitada Sakai Transplantation Proceedings.2023; 55(7): 1649. CrossRef
Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin World Journal of Gastroenterology.2023; 29(27): 4236. CrossRef
Case 30-2023: A 50-Year-Old Woman with Confusion Richard C. Cabot, Eric S. Rosenberg, David M. Dudzinski, Meridale V. Baggett, Kathy M. Tran, Dennis C. Sgroi, Jo-Anne O. Shepard, Emily K. McDonald, Tara Corpuz, Amulya Nagarur, Theodore T. Pierce, Andrew Z. Fenves, Elan R. Witkowski, Nina B. Gold New England Journal of Medicine.2023; 389(13): 1221. CrossRef
Pretransplant Functional Status Predicts Postoperative Morbidity and Mortality after Liver Transplantation in Patients with Cirrhosis Myung Ji Goh, Jihye Kim, Won Hyuk Chang, Dong Hyun Sinn, Geum-Yeon Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Jong Man Kim, Wonseok Kang Gut and Liver.2023; 17(5): 786. CrossRef
Association between sarcopenia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review and meta-analysis Yuanyuan Li, Yuxin Guo, Xiaoze Wang, Langli Gao Abdominal Radiology.2023; 49(2): 575. CrossRef
Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis—Pathogenesis, Implications and Therapeutic Opportunities Ryma Terbah, Adam Testro, Paul Gow, Avik Majumdar, Marie Sinclair Nutrients.2023; 16(1): 35. CrossRef
Research Progress of Blood-Derived Biomarkers Predicting Prognosis of Liver Cirrhosis 晓丽 胡 Advances in Clinical Medicine.2023; 13(12): 19716. CrossRef
Effects of branched-chain amino acid-rich supplementation on EWGSOP2 criteria for sarcopenia in older adults: a systematic review and meta-analysis Geng-Hao Bai, Meng-Chen Tsai, Han-Wei Tsai, Chun-Chao Chang, Wen-Hsuan Hou European Journal of Nutrition.2022; 61(2): 637. CrossRef
Predictors of Sarcopenia in an Obese Asian Population Min Je Sung, Jun Yong Park, Hye Won Lee, Beom Kyung Kim, Do Young Kim, Sang Hoon Ahn, Seung Up Kim Nutrition and Cancer.2022; 74(2): 505. CrossRef
Psoas Muscle Density Predicts Occurrences of Hepatic Encephalopathy in Patients Receiving Transjugular Intrahepatic Portosystemic Shunts within 1 year Weimin Cai, Hanyu Lin, Ruyi Qi, Xinran Lin, Yuan Zhao, Weizhen Chen, Zhiming Huang CardioVascular and Interventional Radiology.2022; 45(1): 93. CrossRef
Effects of Branched-Chain Amino Acids on Parameters Evaluating Sarcopenia in Liver Cirrhosis: Systematic Review and Meta-Analysis Abdulrahman Ismaiel, Camelia Bucsa, Andreea Farcas, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu Frontiers in Nutrition.2022;[Epub] CrossRef
Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy Simone Di Cola, Silvia Nardelli, Lorenzo Ridola, Stefania Gioia, Oliviero Riggio, Manuela Merli Journal of Clinical Medicine.2022; 11(3): 611. CrossRef
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management Paolo Gallo, Marianna Silletta, Antonio De Vincentis, Federica Lo Prinzi, Francesca Terracciani, Giuseppina Di Fazio, Valentina Flagiello, Umberto Vespasiani Gentilucci, Raffaele Antonelli Incalzi, Antonio Picardi Chemotherapy.2022; 67(3): 152. CrossRef
Effects of supervised exercise on aerobic capacity and quality of life in patients with chronic liver disease and patients who underwent liver transplantation: a systematic review and meta-analysis Yoo Jin Choo, Chan Woo Cho, Min Cheol Chang International Journal of Rehabilitation Research.2022; 45(1): 1. CrossRef
Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song Clinical and Molecular Hepatology.2022; 28(2): 219. CrossRef
Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis Takumi Kawaguchi, Takuji Torimura Clinical and Molecular Hepatology.2022; 28(2): 177. CrossRef
The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls Hae Lim Lee, Sung Won Lee Clinical and Molecular Hepatology.2022; 28(2): 121. CrossRef
Amino acids, ammonia, and hepatic encephalopathy Katerina Kroupina, Chantal Bémeur, Christopher F. Rose Analytical Biochemistry.2022; 649: 114696. CrossRef
Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy Myung Ji Goh, Wonseok Kang, Woo Kyoung Jeong, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik Scientific Reports.2022;[Epub] CrossRef
Hepatic encephalopathy Dieter Häussinger, Radha K. Dhiman, Vicente Felipo, Boris Görg, Rajiv Jalan, Gerald Kircheis, Manuela Merli, Sara Montagnese, Manuel Romero-Gomez, Alfons Schnitzler, Simon D. Taylor-Robinson, Hendrik Vilstrup Nature Reviews Disease Primers.2022;[Epub] CrossRef
The sex‐specific prognostic utility of sarcopenia in cirrhosis Ryan Lowe, Penelope Hey, Marie Sinclair Journal of Cachexia, Sarcopenia and Muscle.2022; 13(6): 2608. CrossRef
Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations Camille Pichon, Maxime Nachit, Justine Gillard, Greetje Vande Velde, Nicolas Lanthier, Isabelle A. Leclercq Frontiers in Nutrition.2022;[Epub] CrossRef
Hepatic Encephalopathy Vickie Reed Critical Care Nursing Clinics of North America.2022; 34(3): 331. CrossRef
Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim, Joo Won Baik, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun Clinical and Molecular Hepatology.2022; 28(4): 876. CrossRef
Skeletal muscle mass index as a predictor of long-term cirrhosis onset in young non-cirrhotic males with acute-on-chronic liver failure Jie Bai, Manman Xu, Fengling Peng, Junwei Gong, Jinqiu Zhao, Xiaodong Song, Yongguo Li Frontiers in Nutrition.2022;[Epub] CrossRef
Hyperammonemia in azotemic cats Lauren Carvalho, Denise Kelley, Mary Anna Labato, Cynthia RL Webster Journal of Feline Medicine and Surgery.2021; 23(8): 700. CrossRef
Glucagon Receptor Inhibition Reduces Hyperammonemia and Lethality in Male Mice with Urea Cycle Disorder Katie Cavino, Biin Sung, Qi Su, Erqian Na, Jinrang Kim, Xiping Cheng, Jesper Gromada, Haruka Okamoto Endocrinology.2021;[Epub] CrossRef
Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge Hiroteru Kamimura, Takeki Sato, Kazuki Natsui, Takamasa Kobayashi, Tomoaki Yoshida, Kenya Kamimura, Atsunori Tsuchiya, Toshiko Murayama, Junji Yokoyama, Hirokazu Kawai, Masaaki Takamura, Shuji Terai International Journal of Molecular Sciences.2021; 22(3): 1425. CrossRef
An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia Young Joo Yang, Dong Joon Kim International Journal of Molecular Sciences.2021; 22(5): 2604. CrossRef
Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim Cancers.2021; 13(14): 3424. CrossRef
Definition of Sarcopenia in Chronic Liver Disease Seong Wan Son, Do Seon Song, U Im Chang, Jin Mo Yang Life.2021; 11(4): 349. CrossRef
Skeletal muscle atrophy: From mechanisms to treatments Lin Yin, Na Li, Weihua Jia, Nuoqi Wang, Meidai Liang, Xiuying Yang, Guanhua Du Pharmacological Research.2021; 172: 105807. CrossRef
Identifying areas of improvement in nursing knowledge regarding hepatic encephalopathy management Aalam Sohal, Victoria Green, Sunny Sandhu, Marina Roytman Journal of Community Hospital Internal Medicine Perspectives.2021; 11(5): 722. CrossRef
Hepatische Enzephalopathie und Sarkopenie: pathogenetische Bedeutung und therapeutische Implikationen von Ammoniak M. Kluge, M. Demir, Frank Tacke Der Gastroenterologe.2021; 16(3): 160. CrossRef
Synbiotics Alleviate Hepatic Damage, Intestinal Injury and Muscular Beclin-1 Elevation in Rats after Chronic Ethanol Administration Yi-Hsiu Chen, Wan-Chun Chiu, Qian Xiao, Ya-Ling Chen, Hitoshi Shirakawa, Suh-Ching Yang International Journal of Molecular Sciences.2021; 22(22): 12547. CrossRef
Systematic computer analysis of ornithine research to identify the most promising trends in therapeutic use - focus on liver function O. A. Gromova, I. Yu. Torshin, L. B. Lazebnik, V. A. Maksimov Experimental and Clinical Gastroenterology.2021; (7): 30. CrossRef
Exercise and physical activity in cirrhosis: opportunities or perils Annette Bellar, Nicole Welch, Srinivasan Dasarathy Journal of Applied Physiology.2020; 128(6): 1547. CrossRef
Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian Longitudinal Study on Aging Vincenzo Solfrizzi, Emanuele Scafato, Carlo Custodero, Francesca Loparco, Alessandro Ciavarella, Francesco Panza, Davide Seripa, Bruno Pietro Imbimbo, Madia Lozupone, Nicola Napoli, Giuseppina Piazzolla, Lucia Galluzzo, Claudia Gandin, Marzia Baldereschi, Alzheimer's & Dementia: Translational Research & Clinical Interventions.2020;[Epub] CrossRef
Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Gi Soo Youn, Tae Suk Kim, Baek Gyu Jun, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Dong Joon Kim, Soon Koo Baik, Dae Hee Choi, Ki Tae Suk Cancers.2020; 12(11): 3347. CrossRef
Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B Kyung Hyun Kim, Dong Jin Joo, Yong-ho Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim Digestive and Liver Disease.2020; 52(11): 1338. CrossRef
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis Daniela Campion, Ilaria Giovo, Paola Ponzo, Giorgio M Saracco, Federico Balzola, Carlo Alessandria World Journal of Hepatology.2019; 11(6): 489. CrossRef
Dae Hoe Gu, Moon Young Kim, Yeon Seok Seo, Sang Gyune Kim, Han Ah Lee, Tae Hyung Kim, Young Kul Jung, Altay Kandemir, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um
Clin Mol Hepatol 2018;24(3):319-330. Published online April 30, 2018
Background/Aims The most widely used method for diagnosing sarcopenia is the skeletal muscle index (SMI). Several studies have suggested that psoas muscle thickness per height (PMTH) is also effective for detecting sarcopenia and predicting prognosis in patients with cirrhosis. The aim of this study was to evaluate the optimal cutoff values of PMTH for detecting sarcopenia in cirrhotic patients.
Methods All cirrhotic patients who underwent abdominal computed tomography (CT) scan including L3 and umbilical levels for measuring SMI and transverse psoas muscle thickness, respectively, were included. Two definitions of sarcopenia were used: (1) sex-specific cutoffs of SMI (≤52.4 cm2 /m2 in men and ≤38.5 cm2 /m2 in women) for SMI-sarcopenia and (2) cutoff of PMTH (<16.8 mm/m) for PMTH-sarcopenia.
Results Six hundred fifty-three patients were included. The average age was 53.6 ± 10.2 years, and 499 patients (76.4%) were men. PMTH correlated well with SMI in both men and women (P<0.001). Two hundred forty-one (36.9%) patients met the criteria for SMI-sarcopenia. The best PMTH cutoff values for predicting SMI-sarcopenia were 17.3 mm/m in men and 10.4 mm/m in women, and these were defined as sex-specific cutoffs of PMTH (SsPMTH). The previously published cutoff of PMTH was defined as sex-nonspecific cutoff of PMTH (SnPMTH). Two hundred thirty (35.2%) patients were diagnosed with SsPMTH-sarcopenia, and 280 (44.4%) patients were diagnosed with SnPMTH-sarcopenia. On a multivariate Cox regression analysis, SsPMTH-sarcopenia (hazard ratio [HR], 1.944; 95% confidence interval [CI], 1.144–3.304; P=0.014) was significantly associated with mortality, while SnPMTH-sarcopenia was not (HR, 1.446; 95% CI, 0.861–2.431; P=0.164).
Conclusions PMTH was well correlated with SMI in cirrhotic patients. SsPMTH-sarcopenia was an independent predictor of mortality in these patients and more accurately predicted mortality compared to SnPMTH-sarcopenia.
Citations
Citations to this article as recorded by
Sarcopenia in patients receiving TIPS is independently associated with increased risk of complications and mortality Emma Vanderschueren, Philippe Meersseman, Alexander Wilmer, Vincent Vandecaveye, Evelyne Dubois, Anne Van Eldere, Jan Clerick, Jo P. Peluso, Eveline Claus, Lawrence Bonne, Chris Verslype, Geert Maleux, Wim Laleman Digestive and Liver Disease.2025; 57(2): 549. CrossRef
The prognostic significance of sarcopenia in patients treated with definitive radiotherapy: A systematic review Alexander J. Vickers, Dónal M. McSweeney, Ananya Choudhury, Jamie Weaver, Gareth Price, Alan McWilliam Radiotherapy and Oncology.2025; 203: 110663. CrossRef
Low Skeletal Muscle Index as a Predictor of Pathological Complete Response in HER-2 Positive and Triple-Negative Breast Cancer Murat Günaltılı, Murad Guliyev, Mehmet Cem Fidan, Zeliha Birsin, Emir Çerme, Vali Aliyev, Hamza Abbasov, Selin Cebeci, Seda Jeral, Özkan Alan, Nebi Serkan Demirci, Çiğdem Papila, Onur Erdem Şahin, Said Erkam Bıyıkoğlu, Tülin Öztürk, Berrin Papila Medicina.2025; 61(9): 1508. CrossRef
Sarcopenia in Colorectal Cancer Surgery—Minimally Invasive vs. Open Felix Merboth, Miriam Müller‐Oerlinghausen, Heiner Nebelung, Andreas Bogner, Mathieu Pecqueux, Nadja Salisch, Marius Distler, Verena Plodeck, Ralf‐Thorsten Hoffmann, Johannes Fritzmann, Jürgen Weitz, Johanna Kirchberg Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub] CrossRef
Risk factors and prediction model for sarcopenia in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt Shuyue Tuo, Jia Yuan, Ying Liu, Zhang Wen, Qiuju Ran, Yong Li, Chan Li, Quanxin Yang, Jinhai Wang, Lu Li, Shejiao Dai, Xinxing Tantai Internal and Emergency Medicine.2025;[Epub] CrossRef
Role of the psoas muscle thickness-to-height ratio in predicting pulmonary complications and 30-day mortality after liver transplantation Chuan Li, Hong-Xia Chen, Fei-Xiong Pang, Feng-Feng Liu, Ying-Zhou Zhang, Hong-Jun Liu, Xiang Nong, Yu-Ju Xu, Yan-Hua Lai Asian Journal of Surgery.2025;[Epub] CrossRef
Effect of Sarcopenia on Coronary Atherosclerotic Burden, Lesion Complexity, and Major Cardiovascular Events in Elderly Patients With Acute Coronary Syndrome: A 1-year Follow-up Study Merve Erkan, İsmet Zengin, Süleyman Bekircavuşoğlu, Dursun Topal, Turhan Bulut, Hakan Erkan Angiology.2024; 75(7): 651. CrossRef
Effects of sarcopenia on in-hospital results and mid-term follow-up in patients with coronary artery disease and COVID-19 Merve ERKAN, İsmet ZENGİN The European Research Journal.2024; 10(1): 70. CrossRef
Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis Shuyue Tuo, Yee Hui Yeo, Rachel Chang, Zhang Wen, Qiuju Ran, Longbao Yang, Qing Fan, Junxiu Kang, Jiaojiao Si, Yi Liu, Haitao Shi, Yong Li, Jia Yuan, Na Liu, Shejiao Dai, Xiaoyan Guo, Jinhai Wang, Fanpu Ji, Xinxing Tantai Clinical Nutrition.2024; 43(1): 84. CrossRef
Computed tomography-based abdominal sarcopenic indices and bio-impedance analysis-based skeletal muscle mass index in hemodialyzed patients Maiko Arao, Takahiro Yajima Clinical Nutrition ESPEN.2024; 59: 21. CrossRef
Pre-operative psoas muscle index, a surrogate for sarcopenia; as a predictor of post-esophagectomy complications Tan Yunrong, Wong Wei Jin, Hans Alexander Mahendran, Yoong Boon Koon, Shukri Jahit, Muhammad Arif Kamaruddin, Nor'Aini Anuar, Noor Aida Mat Daud Diseases of the Esophagus.2024;[Epub] CrossRef
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis Elton Dajti, Susana G. Rodrigues, Federica Perazza, Luigi Colecchia, Giovanni Marasco, Matteo Renzulli, Giovanni Barbara, Francesco Azzaroli, Annalisa Berzigotti, Antonio Colecchia, Federico Ravaioli JHEP Reports.2024; 6(8): 101113. CrossRef
Skeletal muscle mass and quality in gout patients versus non-gout controls: A computed tomography imaging study Allyson Covello, Michael Toprover, Cheongeun Oh, Gregoire Leroy, Ada Kumar, Brian LaMoreaux, Michael Mechlin, Theodore R. Fields, Michael H. Pillinger, Fabio Becce Joint Bone Spine.2024; 91(5): 105743. CrossRef
The Impact of Sarcopenia on the Clinical Outcomes of Percutaneous Kyphoplasty in Patients With Osteoporotic Vertebral Compression Fracture: A Retrospective Cohort Study Shan Wu, Dian Zhong, Guosheng Zhao, Yang Liu, Zhenyong Ke, Yang Wang Geriatric Orthopaedic Surgery & Rehabilitation.2024;[Epub] CrossRef
Georg Schmorl Prize of the German Spine Society (DWG) 2023: the influence of sarcopenia and paraspinal muscle composition on patient-reported outcomes: a prospective investigation of lumbar spinal fusion patients with 12-month follow-up Henryk Haffer, Maximilian Muellner, Erika Chiapparelli, Yusuke Dodo, Gaston Camino-Willhuber, Jiaqi Zhu, Ek T. Tan, Matthias Pumberger, Jennifer Shue, Andrew A. Sama, Frank P. Cammisa, Federico P. Girardi, Alexander P. Hughes European Spine Journal.2024; 33(5): 1737. CrossRef
Diffusion-tensor magnetic resonance imaging as a non-invasive assessment of extracellular matrix remodeling in lumbar paravertebral muscles of rats with sarcopenia Xin-Chen Huang, Ji-Yao Ma, Chao Gao, Jia-Xin Chen, Chun-Li Li, Yi-Long Huang, Bo He BMC Musculoskeletal Disorders.2024;[Epub] CrossRef
The cross-sectional area of gluteal muscle on multiaxial CT scan as a predictor for diagnosing sarcopenia in patients with degenerative lumbar disease Dae-Woong Ham, Jeuk Lee, GilWon Choi, Byung-Taek Kwon, Kwang-Sup Song European Spine Journal.2024; 33(10): 3857. CrossRef
The impact of appendicular skeletal muscle index and trunk muscle index on stress urinary incontinence risk in female adults: a retrospective study Junwei Wang, Cunming Zhang, Aiwei Zhang Frontiers in Nutrition.2024;[Epub] CrossRef
Psoas muscle index in sarcopenia following transjugular intrahepatic portosystemic shunt: A multicenter, retrospective study Tongqiang Li, Ze Wang, Yang Liu, Liguo Dai, Xiaoli Zhu, Jiacheng Liu, Qikun Guo, Weijie Luo, Yaowei Bai, Wei Luo, Menglan Chu, Duiping Feng, Bin Xiong Portal Hypertension & Cirrhosis.2024; 3(4): 173. CrossRef
Lumbar Magnetic Resonance Imaging Shows Sex-Specific Alterations During Musculoskeletal Aging—A Radio-Anatomic Investigation Involving 202 Individuals Horst Balling, Boris Michael Holzapfel, Wolfgang Böcker, Dominic Simon, Paul Reidler, Joerg Arnholdt Journal of Clinical Medicine.2024; 13(23): 7233. CrossRef
Psoas Muscle Index as a Predictor of Perioperative Outcomes in Geriatric Patients Undergoing Spine Surgery Mark N. Pernik, William H. Hicks, Omar S. Akbik, Madelina L. Nguyen, Ivan Luu, Jeffrey I. Traylor, Palvasha R. Deme, Luke J. Dosselman, Kristen Hall, Sarah A. Wingfield, Salah G. Aoun, Carlos A. Bagley Global Spine Journal.2023; 13(7): 2016. CrossRef
A Comparative Analysis of Frailty, Disability, and Sarcopenia With Patient Characteristics and Outcomes in Adult Spinal Deformity Surgery Omar S. Akbik, Nadeem Al-Adli, Mark N. Pernik, William H. Hicks, Kristen Hall, Salah G. Aoun, Carlos A. Bagley Global Spine Journal.2023; 13(8): 2345. CrossRef
Sarcopenia in the Cirrhotic Patient: Current Knowledge and Future Directions Edgewood R. Warner II, Sanjaya K. Satapathy Journal of Clinical and Experimental Hepatology.2023; 13(1): 162. CrossRef
Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol Florian Huemer, Stefan Hecht, Bernhard Scharinger, Verena Schlintl, Gabriel Rinnerthaler, Konstantin Schlick, Ronald Heregger, Thomas Melchardt, Angela Wimmer, Iris Mühlbacher, Oliver Owen Koch, Daniel Neureiter, Eckhard Klieser, Sara Seyedinia, Mohsen Be Journal of Cancer Research and Clinical Oncology.2023; 149(7): 3051. CrossRef
Sarcopenia does not limit overall survival in patients with colorectal liver metastases undergoing interstitial brachytherapy Maximilian Thormann, Franziska Heitmann, Vanessa Wrobel, Felix Barajas Ordonez, Maciej Pech, Alexey Surov, Robert Damm, Jazan Omari RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.2023; 195(03): 217. CrossRef
Psoas Muscle Index: A Simple and Reliable Method of Sarcopenia Assessment on Computed Tomography Scan in Chronic Liver Disease and its Impact on Mortality Gajanan A. Rodge, Usha Goenka, Surabhi Jajodia, Rachit Agarwal, Shivaraj Afzalpurkar, Akash Roy, Mahesh K. Goenka Journal of Clinical and Experimental Hepatology.2023; 13(2): 196. CrossRef
Robotic Esophagectomy Compared With Open Esophagectomy Reduces Sarcopenia within the First Postoperative Year: A Propensity Score-Matched Analysis Felix Merboth, Heiner Nebelung, Natalie Wotschel, Hendrik Liebscher, Franziska Eckert, Janusz von Renesse, Jasmin Hasanovic, Thilo Welsch, Johannes Fritzmann, Daniel E. Stange, Verena Plodeck, Ralf-Thorsten Hoffmann, Marius Distler, Jürgen Weitz, Johanna Journal of Thoracic Oncology.2023; 18(2): 232. CrossRef
Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis” Do Seon Song, U Im Chang, Jin Mo Yang Clinical and Molecular Hepatology.2023; 29(1): 165. CrossRef
Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt Tongqiang Li, Jiacheng Liu, Jianbo Zhao, Yaowei Bai, Songjiang Huang, Chongtu Yang, Yingliang Wang, Chen Zhou, Chaoyang Wang, Shuguang Ju, Yang Chen, Wei Yao, Bin Xiong Digestive Diseases and Sciences.2023; 68(4): 1641. CrossRef
Musculus psoas major morphology - a novel predictor of mortality in elderly polytraumatized patients Gregor Wollner, Valerie Weihs, Stephan Frenzel, Silke Aldrian, Lukas Leopold Negrin BMC Emergency Medicine.2023;[Epub] CrossRef
Sarcopenia is an independent risk factor for failure to achieve the 1-year MCID of the KOOS, JR and PROMIS PF-SF10a after TKA Tyler J. Humphrey, Mehdi S. Salimy, Jeffrey M. Jancuska, Cameron R. Egan, Christopher M. Melnic, Kyle Alpaugh, Hany S. Bedair The Knee.2023; 42: 64. CrossRef
Sarcopenia is a negative predictive factor for endoscopic remission in patients with Crohn's disease treated with biologics Mauro Grova, Federica Crispino, Marcello Maida, Alessandro Vitello, Sara Renna, Angelo Casà, Lorenzo Tesè, Fabio Salvatore Macaluso, Ambrogio Orlando Digestive and Liver Disease.2023; 55(7): 865. CrossRef
Korean Working Group on Sarcopenia Guideline: Expert Consensus on Sarcopenia Screening and Diagnosis by the Korean Society of Sarcopenia, the Korean Society for Bone and Mineral Research, and the Korean Geriatrics Society Ji Yeon Baek, Hee-Won Jung, Kyoung Min Kim, Miji Kim, Clara Yongjoo Park, Kwang-Pyo Lee, Sang Yoon Lee, Il-Young Jang, Ok Hee Jeon, Jae-Young Lim Annals of Geriatric Medicine and Research.2023; 27(1): 9. CrossRef
Usefulness of the Measurement of Psoas Muscle Volume for Sarcopenia Diagnosis in Patients with Liver Disease Takushi Manabe, Chikara Ogawa, Kei Takuma, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Koji Fujita, Joji Tani, Mitsushige Shibatoge, Asahiro Morishita, Masatoshi Kudo, Tsutomu Masaki Diagnostics.2023; 13(7): 1245. CrossRef
Visceral Fat as a Risk Factor for Periprosthetic Joint Infection After Total Hip and Knee Arthroplasty Amy Z. Blackburn, Akhil Katakam, Thomas Roberts, Tyler J. Humphrey, Mehdi S. Salimy, Cameron R. Egan, Christopher M. Melnic, Hany S. Bedair The Journal of Arthroplasty.2023; 38(9): 1839. CrossRef
Physical activity in sarcopenia: rehabilitation approaches in prevention and treatment of age-related muscle disorders N.V. Polenova, Yu.R. Varaeva, I.V. Pogonchenkova, E.N. Livantsova, A.M. Shchikota, N.N. Shaposhnikova, T.D. Kiknadze, A.V. Starodubova Problems of Balneology, Physiotherapy and Exercise Therapy.2023; 100(2): 52. CrossRef
A Prospective Study of Prevalence and Impact of Sarcopenia on Short-term Mortality in Hospitalized Patients with Liver Cirrhosis Surakshith Thyloor Kenchappa, Samarth Sharma, Mandhir Kumar, Samarjit S. Ghuman, Anil Arora, Piyush Ranjan Journal of Clinical and Experimental Hepatology.2023; 13(6): 946. CrossRef
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease Alessandra Musio, Federica Perazza, Laura Leoni, Bernardo Stefanini, Elton Dajti, Renata Menozzi, Maria Letizia Petroni, Antonio Colecchia, Federico Ravaioli International Journal of Molecular Sciences.2023; 24(8): 7517. CrossRef
Osteosarcopenia in the Spine Beyond Bone Mineral Density Henryk Haffer, Maximilian Muellner, Erika Chiapparelli, Yusuke Dodo, Jiaqi Zhu, Yi Xin Han, Eve Donnelly, Ek T. Tan, Jennifer Shue, Andrew A. Sama, Frank P. Cammisa, Federico P. Girardi, Alexander P. Hughes Spine.2023; 48(14): 984. CrossRef
Determinants of Treatment Toxicity in Patients with Soft Tissue Sarcomas Katja A. Schönenberger, Emilie Reber, Karin Schläppi, Annic Baumgartner, Zeno Stanga, Attila Kollár Nutrition and Cancer.2023; 75(8): 1638. CrossRef
Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinoma Luca Kümmerl, Matthias Kraulich, Wladimir Lesyuk, Adrian Binninger, Peter J. Goebell, Andreas Kahlmeyer Urologic Oncology: Seminars and Original Investigations.2023; 41(9): 392.e1. CrossRef
Sarcopenia in Chronic Liver Disease Kwang Il Seo The Korean Journal of Gastroenterology.2023; 82(5): 233. CrossRef
Reference for normal measurements of psoas muscle among the adult population in Saudi Arabia Mohammad Abdulrahim Wazzan Saudi Journal for Health Sciences.2023; 12(3): 222. CrossRef
Automated major psoas muscle volumetry in computed tomography using machine learning algorithms Felix Duong, Michael Gadermayr, Dorit Merhof, Christiane Kuhl, Philipp Bruners, Sven H. Loosen, Christoph Roderburg, Daniel Truhn, Maximilian F. Schulze-Hagen International Journal of Computer Assisted Radiology and Surgery.2022; 17(2): 355. CrossRef
Preoperative optimization of geriatric and frail patients Sher-Lu Pai, Adam K. Jacob, R. Doris Wang International Anesthesiology Clinics.2022; 60(1): 33. CrossRef
Association Between Sarcopenia and Adverse Events Following Transcatheter Aortic Valve Implantation Andrew D. Brown, Ben Li, Samantha Gabriel, Robert J. Cusimano, Jennifer Chung, Eric Horlick, Mark D. Osten, Maral Ouzounian, Graham Roche-Nagle CJC Open.2022; 4(2): 173. CrossRef
Brain CT can predict low lean mass in the elderly with cognitive impairment: a community-dwelling study Yun-Ting Chen, Chiun-Chieh Yu, Yu-Ching Lin, Shan-Ho Chan, Yi-Yun Lin, Nai-Ching Chen, Wei-Che Lin BMC Geriatrics.2022;[Epub] CrossRef
Sarcopenia is highly prevalent in children with autoimmune liver diseases and is linked to visceral fat and parent‐perceived general health Antoinette A. Amevor, Toshifumi Yodoshi, Andrew T. Trout, Jonathan R. Dillman, Ruchi Singh, Ryan Jarvis, Lin Fei, Chunyan Liu, Amy Taylor, Alexander Miethke, Marialena Mouzaki Liver International.2022; 42(2): 394. CrossRef
Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis Xinxing Tantai, Yi Liu, Yee Hui Yeo, Michael Praktiknjo, Ezequiel Mauro, Yuhei Hamaguchi, Cornelius Engelmann, Peng Zhang, Jae Yoon Jeong, Jeroen Laurens Ad van Vugt, Huijuan Xiao, Huan Deng, Xu Gao, Qing Ye, Jiayuan Zhang, Longbao Yang, Yaqin Cai, Yixin Journal of Hepatology.2022; 76(3): 588. CrossRef
Predictors of Sarcopenia in an Obese Asian Population Min Je Sung, Jun Yong Park, Hye Won Lee, Beom Kyung Kim, Do Young Kim, Sang Hoon Ahn, Seung Up Kim Nutrition and Cancer.2022; 74(2): 505. CrossRef
Older cancer patients receiving radiotherapy: a systematic review for the role of sarcopenia in treatment outcomes Nezahat Muge Catikkas, Zumrut Bahat, Meryem Merve Oren, Gulistan Bahat Aging Clinical and Experimental Research.2022; 34(8): 1747. CrossRef
Use of computed tomography for the diagnosis of surgical sarcopenia: Review of recent research advances Yu Xiao, Zhou Xiao‐yue, Wu Yue, Liu Ruo‐tao, Li Xiang‐jie, Wang Xing‐yuan, Wang Qian, Qian Xiao‐hua, Jia Zhen‐yi Nutrition in Clinical Practice.2022; 37(3): 583. CrossRef
Sarcopenia at Abdominal CT in Patients with Cirrhosis James T. Lee Radiology.2022; 303(3): 720. CrossRef
Comparison of muscle fat fraction measurements in the lower spine musculature with non-contrast-enhanced CT and different MR imaging sequences Patrick Trueb, Jonas M. Getzmann, Emanuel Ried, Eva Deininger-Czermak, Helena I. Garcia Schueler, Roman Guggenberger European Journal of Radiology.2022; 150: 110260. CrossRef
Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song Clinical and Molecular Hepatology.2022; 28(2): 219. CrossRef
Psoas muscle measurement as a marker of sarcopenia predicts risk of Grade 4 or 5 baseline chronic kidney disease and its progression Davine Yang, Sameena Iqbal, Khashayar Rafatzand, Celena Scheede‐Bergdahl JCSM Rapid Communications.2022; 5(2): 182. CrossRef
Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study Dong Hyun Sinn, Danbee Kang, Mira Kang, Eliseo Guallar, Yun Soo Hong, Kyung Hyun Lee, Jiyeon Park, Juhee Cho, Geum‐Youn Gwak Hepatology.2022; 76(6): 1746. CrossRef
Primary Tumor Fluorine‐18 Fluorodeoxydglucose (18F‐FDG) Is Associated With Cancer-Associated Weight Loss in Non-Small Cell Lung Cancer (NSCLC) and Portends Worse Survival Santiago Olaechea, Bhavani S. Gannavarapu, Christian Alvarez, Anne Gilmore, Brandon Sarver, Donglu Xie, Rodney Infante, Puneeth Iyengar Frontiers in Oncology.2022;[Epub] CrossRef
Current Approach to the Diagnosis of Sarcopenia in Heart Failure: A Narrative Review on the Role of Clinical and Imaging Assessments Saeid Mirzai, Brendan L. Eck, Po-Hao Chen, Jerry D. Estep, W.H. Wilson Tang Circulation: Heart Failure.2022;[Epub] CrossRef
Effect of Preoperative Sarcopenia, Malnutrition and Functional status on Postoperative Morbidity Following Liver Transplantation Kelika Prakash, Amal Francis Sam, Nandakumar K, Neha Tandon Progress in Transplantation.2022; 32(4): 345. CrossRef
Radiological psoas muscle parameters as a reliable tool for detection of sarcopenia and prediction of short-term survival in liver cirrhosis V. M. Motsiuk, N. O. Pentiuk Reports of Morphology.2022; 28(3): 5. CrossRef
Sarcopenia in children with chronic liver disease: Prevalence and impact on liver transplant outcomes Silvio Veraldi, Andrea Pietrobattista, Giovanna Soglia, Lidia Monti, Tommaso Alterio, Antonella Mosca, Daniela Liccardo, Maria Sole Basso, Claudia Della Corte, Luca Russo, Manila Candusso, Fabrizio Chiusolo, Francesca Tortora, Marco Spada, Giuseppe Maggio Frontiers in Pediatrics.2022;[Epub] CrossRef
Development and external validation of DISPAIR fistula risk score for clinically relevant postoperative pancreatic fistula risk after distal pancreatectomy Akseli Bonsdorff, Poya Ghorbani, Ilkka Helanterä, Timo Tarvainen, Tea Kontio, Hanna Belfrage, Jukka Sirén, Arto Kokkola, Ernesto Sparrelid, Ville Sallinen British Journal of Surgery.2022; 109(11): 1131. CrossRef
Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver Pankaj Puri, Radha K. Dhiman, Sunil Taneja, Puneeta Tandon, Manuela Merli, Anil C. Anand, Anil Arora, Subrat K. Acharya, Jaya Benjamin, Yogesh K. Chawla, Sunil Dadhich, Ajay Duseja, C.E. Eapan, Amit Goel, Naveen Kalra, Dharmesh Kapoor, Ashish Kumar, Kaush Journal of Clinical and Experimental Hepatology.2021; 11(1): 97. CrossRef
Serial Observations of Muscle and Fat Mass as Prognostic Factors for Deceased Donor Liver Transplantation Jisun Lee, Woo Kyoung Jeong, Jae-Hun Kim, Jong Man Kim, Tae Yeob Kim, Gyu Seong Choi, Choon Hyuck David Kwon, Jae-Won Joh, Sang-Yong Eom Korean Journal of Radiology.2021; 22(2): 189. CrossRef
Clinical impact of sarcopenia assessment in patients with liver cirrhosis Giovanni Marasco, Elton Dajti, Federico Ravaioli, Stefano Brocchi, Benedetta Rossini, Luigina Vanessa Alemanni, Giuliano Peta, Laura Bartalena, Rita Golfieri, Davide Festi, Antonio Colecchia, Matteo Renzulli Expert Review of Gastroenterology & Hepatology.2021; 15(4): 377. CrossRef
Imaging Software‐Based Sarcopenia Assessment in Gastroenterology: Evolution and Clinical Meaning Giovanni Marasco, Sinan Sadalla, Giulio Vara, Rita Golfieri, Davide Festi, Antonio Colecchia, Matteo Renzulli, Tatsuo Kanda Canadian Journal of Gastroenterology and Hepatology.2021;[Epub] CrossRef
Definition of Sarcopenia in Chronic Liver Disease Seong Wan Son, Do Seon Song, U Im Chang, Jin Mo Yang Life.2021; 11(4): 349. CrossRef
Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites Jin Wook Lee, Jae Seok Hwang, Woo Jin Chung, Heon Ju Lee, Jung Gil Park, Chang Hyeong Lee, Byung Seok Kim, Jeong Eun Song, Young Oh Kweon, Won Young Tak, Soo Young Park, Se Young Jang, Jeong Ill Suh, Byoung Kuk Jang, Bhagwan Dass PLOS ONE.2021; 16(6): e0253886. CrossRef
Usefulness of computed tomography-measured psoas muscle thickness per height for predicting mortality in patients undergoing hemodialysis Takahiro Yajima, Maiko Arao, Kumiko Yajima, Hiroshi Takahashi Scientific Reports.2021;[Epub] CrossRef
Adverse muscle composition predicts all‐cause mortality in the UK Biobank imaging study Jennifer Linge, Mikael Petersson, Mikael F. Forsgren, Arun J. Sanyal, Olof Dahlqvist Leinhard Journal of Cachexia, Sarcopenia and Muscle.2021; 12(6): 1513. CrossRef
Value of the controlling nutritional status score and psoas muscle thickness per height in predicting prognosis in liver transplantation Xing Dai, Ben Gao, Xin-Xin Zhang, Jiang Li, Wen-Tao Jiang World Journal of Clinical Cases.2021; 9(35): 10871. CrossRef
Low psoas muscle index as an unfavorable factor in children with end‐stage liver disease undergoing liver transplantation Settapong Jitwongwai, Chatmanee Lertudomphonwanit, Thitiporn Junhasavasdikul, Praman Fuangfa, Pornthep Tanpowpong, Goragoch Gesprasert, Suporn Treepongkaruna Pediatric Transplantation.2021;[Epub] CrossRef
The assessment of sarcopenia using psoas muscle thickness per height is not predictive of post-operative complications in IBD Omeed Alipour, Vivian Lee, Tapas K. Tejura, Melissa Lee Wilson, Zoe Memel, Jaehoon Cho, Kyle Cologne, Caroline Hwang, Ling Shao Scandinavian Journal of Gastroenterology.2021; 56(10): 1175. CrossRef
Direct Bilirubin Is More Valuable than Total Bilirubin for Predicting Prognosis in Patients with Liver Cirrhosis Han Ah Lee, Joon Young Jung, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyonggin An, Hyung Joon Yim, Yoon Tae Jeen, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um, Yeon Seok Seo Gut and Liver.2021; 15(4): 599. CrossRef
Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients Walid Kamal Abdelbasset, Gopal Nambi, Shereen H. Elsayed, Samah A. Moawd, Ahmed A. Ibrahim, Anju Verma, Sayed A. Tantawy, Dalia M. Kamel, Ayman K. Saleh, Osama R. Aldhafian, Naif Bin Nwihadh, Zhengwen Liu Disease Markers.2021; 2021: 1. CrossRef
Quantification of skeletal muscle mass: sarcopenia as a marker of overall health in children and adults Leah A. Gilligan, Alexander J. Towbin, Jonathan R. Dillman, Elanchezhian Somasundaram, Andrew T. Trout Pediatric Radiology.2020; 50(4): 455. CrossRef
Age-related degeneration of the lumbar paravertebral muscles: Systematic review and three-level meta-regression A. Dallaway, C. Kite, C. Griffen, M. Duncan, J. Tallis, D. Renshaw, J. Hattersley Experimental Gerontology.2020; 133: 110856. CrossRef
Novel Insights into the Pathogenesis of Spinal Sarcopenia and Related Therapeutic Approaches: A Narrative Review Yu-Kai Kuo, Yu-Ching Lin, Ching-Yu Lee, Chih-Yu Chen, Jowy Tani, Tsung-Jen Huang, Hsi Chang, Meng-Huang Wu International Journal of Molecular Sciences.2020; 21(8): 3010. CrossRef
Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study Jung Gil Park, Won Young Tak, Soo Young Park, Young Oh Kweon, Woo Jin Chung, Byoung Kuk Jang, Si Hyun Bae, Heon Ju Lee, Jae Young Jang, Ki Tae Suk, Myung Jin Oh, Jeong Heo, Hyun Young Woo, Se Young Jang, Yu Rim Lee, June Sung Lee, Do Young Kim, Seok Hyun Nutrients.2020; 12(5): 1429. CrossRef
Survival Outcomes According to Body Mass Index in Hepatocellular Carcinoma Patient: Analysis of Nationwide Cancer Registry Database Boram Cha, Jung Hwan Yu, Young-Joo Jin, Young Ju Suh, Jin-Woo Lee Scientific Reports.2020;[Epub] CrossRef
Tongue thickness in health vs cirrhosis of the liver: Prospective observational study Manish Tandon, Harshita Singh, Nishant Singla, Priyanka Jain, Chandra Kant Pandey World Journal of Gastrointestinal Pharmacology and Therapeutics.2020; 11(3): 59. CrossRef
mTOR Inhibitor Therapy for Tuberous Sclerosis Complex: Longitudinal Study of Muscle Mass Determined by Abdominal Cross-sectional Imaging with CT and MRI Caroline Raab, Leah A. Gilligan, Andrew T. Trout, Darcy A. Krueger, David N. Franz, Bin Zhang, Alexander J. Towbin Radiology: Imaging Cancer.2020; 2(5): e190091. CrossRef
Impact of Sarcopenia on Survival in Patients With Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy James M Taylor, Andrew Song, Allison R David, Victor E Chen, Bo Lu, Maria Werner-Wasik Cureus.2020;[Epub] CrossRef
Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Gi Soo Youn, Tae Suk Kim, Baek Gyu Jun, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Dong Joon Kim, Soon Koo Baik, Dae Hee Choi, Ki Tae Suk Cancers.2020; 12(11): 3347. CrossRef
Large-scale analysis of iliopsoas muscle volumes in the UK Biobank Julie A. Fitzpatrick, Nicolas Basty, Madeleine Cule, Yi Liu, Jimmy D. Bell, E. Louise Thomas, Brandon Whitcher Scientific Reports.2020;[Epub] CrossRef
Usefulness of Psoas Muscle Cross-Sectional Area in Evaluating Physical Performance in Patients with Liver Cirrhosis Bo Seong Jang, Han Eum Choi, Jae Hyun Lee, Young Joo Sim, Ghi Chan Kim, Ho Joong Jeong Kosin Medical Journal.2020; 35(2): 133. CrossRef
Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease Min Kyu Kang, Kyeong Ok Kim, Min Cheol Kim, Jung Gil Park, Byung Ik Jang Digestive Diseases.2020; 38(6): 507. CrossRef
Sarcopenia: revised European consensus on definition and diagnosis Alfonso J Cruz-Jentoft, Gülistan Bahat, Jürgen Bauer, Yves Boirie, Olivier Bruyère, Tommy Cederholm, Cyrus Cooper, Francesco Landi, Yves Rolland, Avan Aihie Sayer, Stéphane M Schneider, Cornel C Sieber, Eva Topinkova, Maurits Vandewoude, Marjolein Visser, Age and Ageing.2019; 48(1): 16. CrossRef
Predicting Future Complications of Cirrhosis Joel Wedd, Kavitha Nair Current Hepatology Reports.2019; 18(1): 9. CrossRef
Association of loss of muscle mass with mortality in liver cirrhosis without or before liver transplantation Ke-Vin Chang, Jin-De Chen, Wei-Ting Wu, Kuo-Chin Huang, Der-Sheng Han Medicine.2019; 98(9): e14373. CrossRef
Anthropometric measures associated with sarcopenia in outpatients with liver cirrhosis Lívia A.A. Santos, Talles B. Lima, Marjorie do Val Ietsugu, Hélio R. de Carvalho Nunes, Xingshun Qi, Fernando G. Romeiro Nutrition & Dietetics.2019; 76(5): 613. CrossRef
The value of different CT‐based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis Rafael Paternostro, Katharina Lampichler, Constanze Bardach, Ulrika Asenbaum, Clara Landler, David Bauer, Mattias Mandorfer, Remy Schwarzer, Michael Trauner, Thomas Reiberger, Arnulf Ferlitsch Liver International.2019; 39(12): 2374. CrossRef
Muscle psoas indices measured by ultrasound in cirrhosis — Preliminary evaluation of sarcopenia assessment and prediction of liver decompensation and mortality Andrej Hari, Annalisa Berzigotti, Borut Štabuc, Nina Caglevič Digestive and Liver Disease.2019; 51(11): 1502. CrossRef
Controversies in Diagnosing Sarcopenia in Cirrhosis—Moving from Research to Clinical Practice Marie Sinclair Nutrients.2019; 11(10): 2454. CrossRef
Prognostic implications of trunk muscle mass in liver cirrhosis Jimin Han, Won Kim Clinical and Molecular Hepatology.2018; 24(3): 297. CrossRef
First
Prev
